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ABSTRACT 
Cystic Echinococcosis is a zoonotic infection of humans caused by the metacestode 
(larval) stages of the cestode  Echinococcus granulosus  (family Taeniidae). 
Diagnosis of the infection often involves immunodiagnostic approaches using cyst 
fluid antigens and these have also been used in serological follow up of patients after 
surgical treatment or chemotherapy. However the usefulness of other metacestode 
antigenic extracts for these purposes has not been fully investigated.  
The laminated layer  is a polysaccharide/protein complex that surrounds the outside 
of the hydatid cyst and is a structure unique to the genus Echinococcus. In the 
current study a crude extract of this layer was prepared by sonication and tested for 
reactivity against sera from hydatid patients from Turkana, Kenya. This extract 
reacted both in ELISA and in Immunoblotting, primarily recognising antigenic bands 
around 55 kDa and 12-36 kDa. This latter region appeared to be more specific in 
terms of total IgG and IgG1 and IgG 4 subclass responses. The glycoproteins in this 
region also bound particular lectins such as soyabean Aglutinin and a lectin affinity 
purification column was produced to try and isolate the more specific glycoproteins. 
However this part of the project was not successful and no purified fraction was 
produced. The crude laminated layer extract was then compared with hydatid fluid to 
look for differences in antibody profile in treated and untreated Turkana patients over 
time in an attempt to identify possible markers of disease progression/regression. 
Sera were obtained from 10 albendazole treated patients over time courses ranging 
from 9 months to several years. Similar samples were also obtained from 4 patients 
who had refused treatment. Samples were analysed by ELISA against against 
Hydatid cyst fluid(HCF) and Laminated layer(LL) .  Results of the time courses 
showed that antibody levels fluctuated in both treated and untreated patients and 
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that some of these changes were associated with changes in cyst morphology. In 
some cases the laminated layer showed similar recognition patterns to HCF but in 
others there were peaks of activity against one antigen which was not evident 
against the other. 
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CHAPTER 1 
 INTRODUCTION 
 
1.1 Echinococcosis 
The genus Echinococcus of cestode parasites belonging to the family Taeniidae 
includes also the well-known tapeworms such as Taeniasaginata. Echinococcus 
species have life cycles that always involve a definitive host harbouring an adult 
worm, and an intermediate host carrying the metacestode or the larva. The definitive 
host (mostly carnivore) become infected by the ingestion of protoscolices that are  
contained in the bladder-like metacestode lodged in intermediate host viscera (Diaz 
et.al, 2011)  Protoscolices later develop into 3mm long gut –dwelling adult 
tapeworms, which produce eggs. The intermediate host is infected by accidentally 
ingesting eggs passed out with faeces from definitive host. Hydatid disease is the 
term associated with infection by larval Ehinococcus (Diaz et. al, 2011). Traditionally, 
four species are recognised in the genus. They are Echinococcus granulosus, 
Echinococcus multilocularis, Echinococcus oligarthrus and Echinococcus vogeli. 
Canids are definitive hosts for all species in the genus with the lion strain of E. 
granulosus being an exception (Diaz et. al, 2011).Domestic ungulates mainly act as 
intermediate hosts for E. granulosus, while wild rodents and  
lagomorphs carry out this role for the other three species. 
 
 Humans are accidental intermediate host for the genus. The major concern 
associated with Echinococcus is human hydatid disease and this is comprised 
mainly of cystic hydatid disease, which is caused by E. granulosus and alveolar  
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hydatid disease caused by E. multilocularis (Brunetti, et. al, 2010). Cystic hydatid 
disease can remain unobserved for many years, as the slow growing hydatid cyst by 
and large causes pathology only through the compression, contracting and putting 
pressure on the host organ, which is most commonly liver or lung, or any other 
organ. Consequently, symptoms are rather non-specific and are dependent on the 
precise location. Complications not associated with organ contraction can be 
experienced and are also important; they include bacterial superinfection and cyst 
rupture, which can bring about the risk of anaphylactic shock and or the initiation of a 
secondary infection. The disease has a worldwide distribution. It is a highly prevalent 
disease, especially where pastoralism is an important activity and regular dosage of 
domestic dogs with the drug praziquantel have not been allowed due to politics, 
institutional conditions. Hence, cystic hydatid disease is important in areas of Central  
Asia, South America, China, and Africa (Jenkins et. al, 2005). 
 
Alveolar hydatid disease has the liver as the only primary site. After being 
asymptomatic for several years, the infection becomes apparent, initially with 
symptoms such as jaundice and abdominal pain. The host liver parenchyma and in 
some cases, other organs is aggressively invaded by the metacestode, the disease 
becomes grave, even lethal except treated appropriately (Diaz et. al, 2011). 
Restriction of this infection is to the cold and temperate climates in the northern 
hemisphere, significant especially is the Tibetan plateau and some other remote 
areas of China, Hokkaido in Japan and parts of Central Europe (Jenkins et. al, 
2005). 
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1.2    Distribution/Epidemiology 
The genus Echinococcus is an important one because it consists of a number of 
zoonotic species that can cause serious ill health in man. The genus is consisted of 
at least 4 species, but evidence gathered  from recent molecular studies suggests 
there should be a taxonomic revision to at least 5 species or even possibly 6 (Le et 
al, 2002; McManus, 2002; Thompson & McManus, 2002). With the species E. 
granulosus, there is also a significant strain variation. The definitive host with each 
species is a carnivore, whilst the intermediate host could be any of a large number of 
mammalian species. The parasite is pathogenically and economically significant  
in intermediate and unusual intermediate hosts, where the larval parasite develops 
into a hydatid cyst. The genus is distributed worldwide, although geographical 
distribution of a number of species is limited (Torgerson and Budke, 2003). 
 
E.granulosus is distributed globally, it is found on all continents, with highest 
prevalence in parts of Eurasia (especially the Mediterranean countries, the Russian 
Federation and adjacent independent states, and China), East and North Africa, 
Australia and South America (Eckert et al., 2001). According to Eckert et al (2001) 
and Ito et al (2003), there is also clear evidence for the emergence and re-
emergence of human cystic echinococcosis in parts of China, central Asia, Eastern  
Europe, and Israel. Communities that are involved in sheep farming are known to  
harbour the highest rates of infection, emphasising the public health importance of 
the sheep-dog cycle and the sheep strain of E. granulosus in transmission to people. 
(Thompson and McManus, 2001; McManus, 2002).             
Epidemiologically, human cystic echinococcosis occurs mainly in poor pastoral 
communities where sheep and other livestock are raised and dogs are kept for 
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guarding and or herding animals. Transmission of E. granulosus is predominantly in 
a cycle between dog definitive hosts harbouring the small intestinal tapeworm, and  
livestock (especially sheep). The distribution of this parasite in the United Kingdom is 
restricted, being found mainly in mid and southern Wales. The zoonotic strains  
of E.granulosus are present in every country in Europe, except Ireland, Iceland and 
Denmark (Torgerson and Budke, 2003). It is most extremely endemic in large parts 
of China and a significant re-emerging zoonosis in the former Soviet Republics in  
central Asia (Torgerson et al, 2002a,b). 
 
The parasite is also present throughout the Indian subcontinent and the Middle East. 
E.granulosus is widely circulated or diffused in Africa, and of a major problem in 
Northern African countries such as Tunisia, Morrocco, Libya and Algeria. There are 
specific concerns  for the parasite in the South of the Sahara in certain locations like  
the Turkana in Kenya. The parasite is present in Canada and Alaska of the North 
America region, and appears to put on mainly a sylvatic cycle. In the continental 
USA, the parasite occurs at irregular intervals with just a few communities, foci such 
as certain communities in Utah and California (Torgerson and Budke, 2003).  
 
It is also widespread in South America, especially in Argentina, Uruguay and 
Peruvian Andes.  In Australia a sylvatic cycle between dingoes and wallabies  can 
also occur with over 25% of dingoes and up to 65% of macropod marsupials infected  
(Jenkins and Morris, 1995; Jenkins, 2002). 
Echinococcus granulosus can have both sylvatic cycles, which often times involves 
wild carnivores and ungulates; and domestic cycles, with dogs and farm livestock 
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usually involved. The latter transmission cycle is the commonest and presents the 
greater risk, threat to human health. The highest incidence rates in man have  
often being from, or noticed in areas where there are close relationship with man and 
domestic livestock, with man often using dogs as working dogs. The common source 
of infection for dogs is by feeding on offal from infected sheep, which most times 
harbour G1 zoonotic strain that is in many cases responsible for human CE.  
 
Consequently, the high infection levels in these dogs then present a risk to human 
contacts (Torgerson and Burdke, 2003). There is a very high potential for 
transmitting E. granulosus domestically, in poor countries, where level of education 
may be low, inadequate veterinary services and a widespread practice of home 
slaughtering (Torgerson and Burdke, 2003). The infection rates in dogs in such 
circumstances can reach between 20% and 50%, with possibly an excess of 50% of 
the sheep population being infected. The degenerating situation in Central Asia are 
an illustration of the risks associated with infection. CE in man was at relatively low  
levels, prior to the breakup of the Soviet Union. Nevertheless, following the Central 
Asian republics independence, there was diffused economic and structural reform. 
With this came about farm privatisations, centralised meat processing facilities were 
either withdrawn or abandoned, and there was a return to small subsistence-type 
agricultural practices (Torgerson and Burdke, 2003). Lack of government funding 
saw the collapse of veterinary services, resulting in an epidemic of human CE, with 
annual incidence reported surgical cases by hospitals in an excess of 4-5 times the 
number reported prior to 1991 (Torgerson et al, 2002a,b, 2003).  
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Emerging also in other former communist countries like Bulgaria is a similar pattern 
(Todorov and Boeva, 1999).However, providing resources were made available, a 
decrease, reduction in prevalence, even eradication would have been a possibility. 
This mainly is due to the factors that affect dynamics of transmission. 
 
 
 1.3 Public Health Implications 
Worldwide currently, over three million people are afflicted with echinococcosis, and 
the extent of the morbidity associated with both AE and CE is estimated to result in 
more than 1.5million disability adjusted life years (DALY‘S) lost ( Budke et. al, 2006; 
Togerson et al, 2010). AE is of significant public health concern, especially in parts of  
Central and Eastern Europe and notably, Northwest China (Vuitton et. al, 2003). 
Even though, in many endemic areas, the annual incidence of AE may appear low 
(0.03-1.2 per 100 000 inhabitants) (Vuitton et. al, 2003), the estimation is that there 
are many cases remaining undiagnosed (Brunetti et al, 2010). 
 
Endemicity of human CE is in many pastoral communities, especially in eastern 
Europe (Jimenez et. al, 2002) and north China (Whang et. al, 2001). According to 
Eckert et. al, 2000), in many endemic regions and/ or countries, cotransmission of E. 
granulosus and E. multilocularis have been recognised, including Northern Japan, 
China, North Africa, North America and several Eurasian countries.Nearly 95% of all 
AE cases according to Wen and Yang (1977) worldwide are restricted in five 
endemic provinces/ autonomous regions of Sichuan, Quinghai, Gansu, Xinjiang and 
Ningxia, in north and northwest China. AE and CE are co-endemic in all five, with the 
latter being endemic also to a further 16 of the 33 provinces in China. 
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1.4    Life Cycle of Echinococcus granulosus 
Two hosts are required for the life cycle of the parasite, a definitive and an 
intermediate host. Dogs are the main definitive hosts for E. granulosus while foxes 
are for E. multilocularis. The major intermediate hosts for E. granulosus are 
ungulates and wild rodents for E. multilocualris (See review by, Ammann and Eckert, 
1996). The intestine of the definitive host harbours the adult worm and  eggs passed 
out in the faeces are ingested by the intermediate host. Gastroenteric enzymes 
digest the external coating of the eggs, following its oral ingestion and the  
oncosphere larva is freed. The embryos possess hooklets with which they attach  
to the mucosa of the intestine (Tüzün et al, 2002). They penetrate the wall and enter 
the portal venules and lymphatics, from where they are transported to the liver, 
lungs, organs and tissues of the systemic circulation. Ultimately, the oncosphere 
develops into a cyst within which the protoscoleces are produced.  
 
The cycle is completed when viscera containing live larval form are eaten by the 
definitive host (Beggs, 1985; Ersahin et al, 1993;  Ammann and Eckert,1996; Sinner, 
1997; Gossios et al,1997). Humans may become accidentally infected as 
intermediate hosts after directly ingesting parasitic eggs from contact with a definitive 
host or indirectly from contaminated food or water (Ammann and Eckert, 1996 ; 
Gossios et al,1997 ; Tüzün et al, 1998 ; Haliloğlu et al, 1997). Humans are usually 
considered a dead end for the parasite since the life cycle relies on carnivores eating 
infected herbivores (see review by, Zhang et al, 2003).    
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Figure 1.1: Life cycle of Echinococcus granulosus 
(Source: 
http://images.google.co.uk/images?imgurl=http://www.biochemj.org/bj/362/0297/bj3620297f0
1.gif) 
 
 
1.5 Echinococcus Metacestodes 
After eggs have being ingested by the intermediate host, they go on to release 
embryos (oncospheres) that penetrate the gut wall, travel through blood or lymph 
and end up being trapped in internal organs where development into metacestodes 
takes place (Diaz et. al, 2011). These are surrounded by a thin cellular layer known 
as the germinal layer (GL) and fluid filled (hydatid cyst fluid, or vesicle fluid). The GL 
gives rise to brood capsules by budding towards the inside, generating protoscolices 
in return. There are variations to this basic structure amongst species. The E. 
granulosus is typical; it develops as a large unilocular, turgid cyst, which grows 
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through an increase in diameter. E. oligarthrus and E. vogeli develop in similar way 
but tend to form multi-chambered cysts. Growth by E. multilocularis is different and 
contrasting to what is obtained with the other species in that it grows by  
outward budding, thereby giving rise to a labyrinth of chambers and tubules (Diaz et. 
al, 2011). 
 
The GL extends towards the outside, towards the apical plasma membrane of its 
syncytial tegument which carries truncated microtriches (Morseth D.J, 1967). 
Additionally, the GL possess non-syncytial cell types, including muscle, glycogen-
storage and undifferentiated cells. There is neither a syncytial organization nor 
junction complexes between cells towards the cyst cavity, so that the intercellular 
fluid of the GL is apparently continuous with the cyst/ vesicle fluid (Lascano et. al,  
1975) .The laminated layer (LL) is what separates the GL from host cells and / or 
host extracellular matrix. It is an acellular carbohydrate-rich sheath secreted by the 
GL. Approximately, the LL attains 10-12µm in thickness in E. multilocularis, up to 
400µm in E. vogeli and up to 3mm in E. granulosus (Rausch, 1954; Bortoletti and 
Ferretti, 1978; Rausch, et al, 1981).The LL is related to cellular glycocalyses. 
Nonetheless, the inner most strata only of this huge structure are likely to be 
covalently anchored to the GL tegumental membrane. Therefore, the LL can 
appropriately be described as a specialised extracellular matrix, found only in the 
genus Echinococcus, designed evolutionarily for the maintenance of the physical 
integrity of metacestodes and for the protection of GL cells from host immunity. 
There is the probability that the first of these demands determines the impressive 
thickness of the E. granulosus LL: live hydatid cysts are turgid, and also pressure 
from the outside is a significant threat, as depicted by the occurrence of traumatic  
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cyst rupture (Brunetti et. al, 2010). 
 
Budding off from the germinal membrane are the brood capsules and protoscolices 
(PSC) (See review by, Zhang et al, 2003). ―A mature fertile cyst is frequently 
unilocular (having a single cavity) and visualized as a clear (anechoic), fluid-filled 
lesion, usually with a cystwall visible‖ (Rogan et. al, 2006). The cyst wall is made up 
of a syncitial germinal layer that gives rise to brood capsules and protoscolices, and 
a non- living laminated layer adjoining the host tissue. The living germinal layer is not  
distinct or differentiated within the cyst wall in ultrasound. However, cysts vary in 
both size (1-20cm or more) and internal structure (Rogan et al, 2006).              
 
Host tissues usually enclose or surround the parasitic cyst or endocyst to form a 
pericyst. The endocyst is largely consisted of a thick (0.2-2mm) acellular laminated 
layer. A thin (10-20µm) germinal layer may be present in healthy cysts, which lines 
the inside of the laminated layer, which may give rise to brood capsules containing 
protoscolices. The central cavity of a healthy cyst is filled with clear fluid, and varying 
sizes of daughter cysts which are formed by internal growth; may also be present. In 
degenerating, degenerated or dead cysts, a viable germinal layer or protoscolices 
may no longer be contained in the endocyst, there is the possibility of infiltration, it 
may have occurred and pericyst often shows signs of partial or complete 
calcification. (Wang et al, 2003). 
 
The fully developed metacestode is a unilocular cyst, and could reach large size. 
―The cyst cavity is filled with sterile hydatid fluid, which, is a complex mixture of 
parasite-derived molecules and host-derived serum components‖(see review by, 
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Richard  and Lightowlers, 1986; McManus and Bryant, 1995). The cyst wall is 
consisted of an inner thin multinucleated germinal layer and an outer thick acellualr 
laminated layer.  
 
 
 
 
 
Figure 1.2:  Structure of the Hydatid cyst. 
 
(Source:http://images.google.co.uk/images?imgurl=http://pathmicro.med.sc.edu/parasitology
/EchinococcusLifeCycle) 
 
 
 
 
 
1.6    The Laminated Layer 
The laminated layer (LL) is made up of a number of laminations, and in addition to 
giving support to the cyst, it is presumed to protect the parasite from the hosts 
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immune responses. (Coltorti and Varela-Diaz, 1974; Bortoletti and Ferreti, 1978; 
Richards et al, 1983 ; Harris et al, 1989 ; Rogan and Richards, 1989; Holcman et al, 
1994; Gottstein and Felleisen, 1995). It consists of a protein-polysaccharide 
complex: the carbohydrate component appears to be built up of glucose, galactose, 
glucosamine and galactosamine (Kilejian and Schwabe, 1971; McManus and Bryant, 
1986; Leducq and Gabrion, 1982). Protection of the parasite from the hosts immune 
response could stem from the carbohydrate (Coltorti and Varela-Diaz, 1974; Leducq 
and Gabrion, 1982; Rogan and Richards, 1986), presumably inhibiting complement 
activation (Smyth and Mcmanus, 1989). The laminated layer is parasitic in origin, 
secreted by the germinal layer (Bortoletti and Feretti, 1978; Harris et al, 1989; 
Holcman et al, 1994). Both layers, laminated and germinal layers are joined together 
by cystoplasmic connections. 
 
 The germinal layer is made of undifferentiated, proliferative totipotential cells, which 
produce brood capsules that project into the lumen of the mother cyst or daughter 
cysts. Formation of the protoscolex occur from budding of the germinal layer of the 
brood capsules which eventually may break away from their attachment to the 
germinal membrane and form ‖hydatid sand‖ in the cyst fluid. When ingested by the 
definitive host, each protoscolex may develop into adult tapeworm. The cyst wall of 
metacestodes is consisted of inner, middle and external layers, with the middle 
(laminated) layer been unique to the genus Echinococcus when compared with other 
larval Cestodes. The presence of this layer is not noticed in very young cysts until it  
is about 14-18days when it appears first as a thin, clear layer on its outer margin. 
The laminated layer is an acellular, polysaccharide protein complex that is strongly 
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stained by periodic acid, Schiffs reagent (PAS) and in histological studies provides a 
useful marker (Kilejian et  al, 1962 ; Craig et al, 1995). This layer is developed  
from or given rise to by the germinal (inner) layer (Bortoletti and Ferretti, 1978; 
Holcman et al, 1989), and its structure may also be contributed to by host material 
(Kilejian and Schwabe, 1971; Pezzella et al, 1984). It has been shown that more  
galactosamine than glucosamine is contained in the laminated layer (LL) of E. 
granulosus. Nevertheless, there are more glucosamine than galactosamine in 
protoscoleces (Px) and hydatid cyst fluid (HCF). Also presented in this layer is acid 
muco-polysaccharide (Richards, 1984). 
 
 
 
 
 
1.7   Development In The Intermediate Host 
Hatched parasitic embryos migrate through the intestinal mucosa and enter venules 
and lymphatics. Between 60-70% of the embryos are filtered by the liver, and 15-
25% by the lungs, 10-15% reaches other organs via the systemic circulation (Sinner 
et. al, 1991). Undestroyed embryos are transformed into small cysts that will grow 2-
3cm each year. The parasitic cyst wall is consisted of a germinal layer (endocyst) 
and a laminated proteinaceous membrane (ectocyst). The host forms a dense 
fibrous capsule (pericyst) which is in reaction against the cyst, and this contains 
blood vessels that provide nutrients to the parasite (Sinner et. al, 1991). 
In order to comprehend the host-parasite relationship, the knowledge of post-
oncospheral differential is vital since structural changes of the developing hydatid 
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cyst tegument may reflect the parasites immunoprotectivemechanism (Holcman et. 
al, 1994). Mature eggs of E. granulosus possess a thick embryophore and its  
ultrastructure shows it consists of thick elongated blocks that are united by electron-
lucid cement (Holcman et. al, 1997), and surrounding the oncosphere is a thin 
cytoplasmic oncosphere membrane. The most eminent granules of penetration  
glands occupy the region of the nuclei in the hatched oncosphere. Various different 
functions are ascribed to the secretion of the penetration glands. They are involved 
in penetration and are totally pushed out during this process (Holcman et. al, 1997). 
The secretion causes lysis of host tissue in the surrounding of the invading 
oncosphere, enabling the oncosphere to resist the host cellular attack by maintaining 
a zone of necrosis of surrounding cells during the development of laminated layer 
(Heath, 1971).  
 
The penetration glands support and assist in adhesion and protection against 
digestive enzymes or immune response of the host ( Lethbridge, 1980; Fairweather 
and Threadgold, 1981), they may also contribute to the formation of microvilli (Harris 
et. al, 1989; Holcman et al, 1994). There are three recognised types of penetration 
glands (Swiderski, 1983), displaying a range of electron densities (Holcman et. al, 
1994) different functions could be ascribed to different secretions. Harris et. al, 
(1989), suggested that much of the membrane needed for the extension of the 
microvilli from the epithelium could come from the fusion of penetration granule 
membranes with the outer plasma membrane. The three pairs of hooks located in 
the region opposite to the nuclei are equipped with a complex muscle system. 
The oncosphere may be assisted in penetrating the host intestine possibly by 
secretions from the penetration glands. Hooks may be put to work as blender knives 
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to cut tissue for penetration, in contrast to the hooks found on protoscolex or scolex 
which are lacking in independent musculature and only function to provide 
anchorage (Antoniou and Tselentis, 1993). The hook region, seen as the smaller 
lobe at light microscopy is incorporated in the metacestodes eventually (Heath and 
Lawrence, 1981), by day 2-3 after activation. The post-oncospheral development is a 
complex process of acquisition of biochemical and morphological properties difficult 
to be observed in vivo. ―There is a great number of studies on in vitro culture of 
protoscolex from fertile hydatid cysts to adult strobilate stage and a significant 
number on the ultrastructure of E. granulosus protoscolex tegument and of the 
germinal and laminated layers of the hydatid cyst‖ (Morseth, 1967; Bortoletti and 
Ferretti, 1973, 1978; Lascano et al, 1975; Conder et al, 1983, Rogan and Richards, 
1986; Casado et al, 1992). 
 
However, studies on in vitro culture of oncospheres are few, this, perhaps is due to 
the risk associated with handling of E. granulosus eggs (Heath and Smyth, 1970; 
Heath and Lawrence, 1976, 1981) and only two studies deal with ultrastructural 
development of the oncosphere to early metacestode (Harris et. al, 1989, Holcman 
et. al, 1994). In the obvious absence of cell multiplication, cellular reorganization of 
an early metacestode takes place. There is a rapid increase in number and size of 
the microvilli by day 1 and up to day 2. In the epithelium of the metacestodes, 
electron-lucid vesicles start to appear increasing in size and number continuously.  
 
―In a 3days old metacestode, long microvilli are substituted by old short microtriches 
and the first laminated layer surrounding the metacestode appears as an electron-
dense matrix composed of fine microfibrillated material and remnants of depressed 
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microvilli‖. (Holcman& Heath, 1997). This layer is the first of a series that stems from 
the germinal membrane, and eventually appears to be a series of adjacent 
laminations. The large microvilli are completely by day 5 substituted by short and 
microfilamentous microtriches that project into the laminated layer. The appearance 
of the second laminated layer is between day 6-8. Its more electron-dense than the 
first lamination and is represented on its outer and inner surfaces by particulate 
material. 
―Some microtriches appear to open into or be covered by the particulate material of 
the second lamination‖ (Holcman and Heath, 1997,). The laminated layer that 
surrounds the metacestode of the E. granulosus is involved in protection of the 
parasite from the host immune response. Lamination first appears very early in post- 
oncospheral development. The organization of the laminated layer in the early 
metacestode of E. granulosus suggests that the outer sheet of the laminated layer is 
likely to be constantly replaced. The cyclical production possibly, is an intrinsic 
characteristic of the laminated cover essential in the creation of layers that could  
eventually be depressed as the cyst grows, and serve to divert host cellular 
response to the parasite. Before a naive host would be expected to mount an 
antibody-mediated immune response, the full development of the first lamination is 
completed (Holcman and Heath, 1997). 
 
 
 
1.8    Human Hydatidosis 
Human disease in cystic echinococcosis is as a result of the development and 
growth of fluid-filled cysts that are found mainly in the liver and the lungs, although 
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the abdominal cavity, heart, bone, muscle, nervous system, and or other locations 
can be affected (Khuroo, 2002; McManus et al, 2003). The cystic larvae grow slowly, 
and its growth is well tolerated by the host, leading occasionally to large parasitic 
masses (Moro, et al, 1999; McManus et al, 2003). Human echinococcosis occurs 
when eggs that have been shed in the faeces of definitive hosts are ingested by 
man.  
Usually, the initial phase of CE is asymptomatic with small, well encapsulated cysts, 
which after an undefined period of several months to years; the infection may 
become symptomatic as a space-occupying lesion.  
 
However, according to Pawlowski et. al, (2001), 60% of infections will remain 
asymptomatic. The commonest organ involved is the liver, with over two third of 
cysts usually. Infection in the lungs accounts for 20% of cases, with involvement of 
other organs accounting for less than 10% of cases (Torgerson and Burdke, 2003). 
 
 
1.9    Pathology 
Once the establishment of infection has taken place, the parasites are able to 
survive and grow throughout the lifetime of the host. Cysts growth can be 
unrestricted and CE cysts can sometimes reach sizes in excess of 13cm in diameter 
(Yang et. al, 2005). Nevertheless, because the growth of the parasite is very slow, 
often, symptoms arise years after infection when the disease is well advanced. In 
untreated or in inadequately treated AE patients, the mortality rate is more than 90%  
within 10-15 years of infection (Togerson et. al, 2008). The mortality rate due to CE 
is lower (about 2-4%) but significantly increases if medical treatment is inadequate or 
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unavailable (Brunetti et. al, 2010). CE cases remain asymptomatic most times until 
the cyst compresses or ruptures and there is spillage of its contents into 
neighbouring tissues and organs, by which time the disease is well advanced 
already (Brunetti et. al, 2010). 
 
The pathological damage or dysfunction caused by cysts is mainly by the gradual 
process of space-occupying repression or the displacement of vital host tissue, 
vessels or organs. Clinical manifestations are consequently determined primarily by 
the site and number of cysts and these are quite variable. A massive release of cyst 
fluid and dissemination of protoscolices is what can follow and in most cases is what 
follows accidental rupture of cysts, resulting, occasionally in anaphylactic reactions 
and or multiple secondary cystic echinococcosis, since protoscolices have the  
potential of developing into cysts within the intermediate host (Schantz and 
Gottstein, 1986). 
 
There have been reports of cystic echinococcosis presenting for medical attention in 
people that are aged from younger than 1year to older than 75years, with fairly 
similar rates in both sexes. Following surgery on primary cysts, recurrence may 
occur. About 60% of all cases of cystic echinococcosis may be asymptomatic, 
although an unknown proportion may become symptomatic. ―About 0.2 per 
population of 100,000 has been estimated as the mortality rate, with a case fatality 
rate of 2.2%‖ (Menghebat et al, 1993). A good percentage of cysts (90%) occur in 
the liver, lungs, or both. Cysts that are symptomatic have been occasionally reported 
in the spleen, kidney, peritoneal cavity, and the skin muscles (2-3% each); and 
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seldomly in the heart, brain, ovaries, vertebral column (1% or less each) (Menghebat 
et al., 1993). Symptoms presented by cystic echinococcosis can be highly variable,  
and can be dependent not only on the organ involved, but also on size of cysts and 
their position within the organ, the mass effect within the organ and upon 
surrounding structures, and related complications to cyst rupture and secondary 
infection. In response to cyst leakage or rupture, manifestations of systemic 
immunological responses may be evident. Common complications involving cystic 
echinococcosis include rupture into the biliary tree with secondary cholangitis, 
obstruction of the biliary by daughter cysts or extrinsic compression, rupture into the 
bronchial tree, intracystic or subphrenic abscess formation, development of a 
bronchobiliary fistula and intraperitoneal rupture (with or without anaphylaxis). 
 
According to Ammann and Eckert (1996), 10% of all intraperitoneal ruptures had 
anaphylactic complications, with the remaining patients developing multiple 
intraperitoneal cysts, and  anaphylaxis accounted for two of the 221 (0.9%) reported  
complications of cystic echinococcosis. As cysts grow and enlarge, however, they 
can put pressure on surrounding organs and can cause several pathological 
changes (Pawlowski et al, 2001). More common are fever, jaundice and abdominal 
pain, but more serious problems, such as hepatomegaly (enlargement of the liver), 
inflammation of the bile duct (cholangitis) and high blood pressure in the portal 
venous system (portal hypertension) also can occur (Pawlowski et al, 
2001).Complications also arise due to or by the possibility of cyst rupture which can 
result in anaphylactic reactions due to the large amounts of hydatid fluid being 
released. A secondary hydatid infection can result from rupture, caused by the 
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release of many thousands of larvae (protoscolices), with each having the capability 
to differentiate into another hydatid cyst (Rogan et al, 2006). 
 
 
1.10   Diagnosis 
The detection of the space occupying cysts or lesions caused by metacestode(s) of 
Echinococcus species that are developing, dying, or dead is largely dependent on 
imaging techniques. The quality of the management and treatment of cystic 
echinococcosis can be improved essentially by early diagnosis. With the early stages 
of infection being asymptomatic in most cases, cheap methods and that are quite 
easy to use are needed for large-scale screening of populations that are at high risk. 
For most cases  of cystic echinococcosis in man, the definitive diagnosis is usually 
by physical imaging methods, such as computed tomography (CT scanning), 
ultrasonography, radiology and magnetic resonance imaging (MRI), (Pawlowski et 
al,2001), although in isolated communities, such procedures are not readily available 
(Mcmanus et al, 2003; Raether and Hänel, 2003; Polat et al, 2003 ; 
WHO/IWGE,2003; Macpherson and Milner, 2003; Eckert and Deplazes, 2004;  
Kjossev and Losanoff, 2005). The overall method of choice for diagnosing cystic 
echinococcosis is the usage of ultrasound scanning. This choice of method is 
applicable to both community and routine hospital settings (Whang et al, 2003). 
Since the late 1970s, ultrasound has been used for the detection of pathological 
lesions due to CE (Vicary et al, 1977; Macpherson, 1992). The ultrasound scanning 
method has also been used for the examination of hydatid cyst development over 
time (Romig et al, 1986 ; Frider et al, 1999) and post-treatment (Caremani et al, 
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1997 ; Gharbi et al, 1997). Diagnosing CE early can bring about significant 
improvements in the quality of the management and treatment of the disease. Early  
stages of the infection are asymptomatic in most cases, so, cheap and relatively 
easy to use methods are required for large-scale screening of populations at high 
risk. Providing such an approach is immunodiagnosis, which can also confirm clinical 
findings (Zhang et al, 2003). 
 
Immunodiagnosis is vital in that it plays an important as well as a complementary 
role. Its usefulness is not only for primary diagnosis but also for follow-up of patients 
after surgical or pharmacological treatment. Detection of antibody in sera is more 
sensitive than the detection of circulating antigen, and remains the method of choice  
(Zhang et al, 2003). Serological testing of cystic hydatid disease (CE) has a very 
long history, and almost all serological tests that have been developed have been 
used in the diagnosis of human cases. Among the various tests, there are 
considerable differences in sensitivity and specificity. Non-specific and insensitive 
tests, like the Cassoni Intradermal test, the complement fixation test, the latex 
agglutination test, the indirect haemagglutination test have been replaced by the 
enzyme-linked immunosorbent assay (ELISA), the indirect immunofluorescence 
antibody test, immunoelectrophoresis (IEP), and immunoblotting (IB) in routine 
laboratory procedures, applications (Lightowlers and Gottstein, 1995). 
 
―The lipoproteins antigen B (AgB) and antigen 5 (Ag5) (Oriol and Oriol, 1975), the 
major components of hydatid cyst fluid, have received the most attention with regard 
to diagnosis. Along with HCF, they are the most widely used antigens in current 
assays for immunodiagnosis of CE. Both antigens have been well characterized by 
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immunoblotting and or by immunoprecipitation of radiolabelled antigen and SDS-
PAGE‖ (Shepherd and Mcmanus, 1987; see review by, al-Yaman and Knobloch, 
1989; Lightowlers et al, 1989; Shapiro et al, 1992). 
 
―Antigen B, with a molecular mass of 120KDa is a polymeric lipoprotein that can be 
measured as a circulating antigen in patients blood (Kamiya and Sato, 1990; Liu et 
al,1993) has been suggested to play an important role in the biology of the parasite-
host relationship (Shepherd et al, 1991; see review by, Rigano et al,2001). Antigen B 
is a highly immunogenic molecule, appearing ladder like under reduced condition on 
SDS-PAGE, with three bands with molecular sizes of approximately 8 or 12, 16, and 
24KDa (Chordi and Kagan, 1965 ; Oriol et al, 1971 ; Shepherd and Mcmanus, 1987 ; 
Lightowlers et al, 1989 ; Leggatt et al, 1992), suggesting that it comprises polymers 
of 8KDa subunits. The smallest subunit has proved the most useful target in 
diagnostic studies‖ (Ortona et al, 2000; Rott et al, 2000). 
 
Ag5 is a lipoprotein with a very high molecular mass complex composed of 57 and 
67KDa components that dissociates into 38 and 22 to 24KDa subunits under 
reducing conditions (Lightowlers et al, 1989). ―According to history, the 
demonstration of serum antibodies precipitating antigen 5 (arc5) by 
immunoelectrophoresis or similar techniques has been one of the most widely used 
immunodiagnostic procedures for CE‖ (Shepherd and McManus, 1987). 
The current standard of practice for serology for human cystic echinococcosis is 
based on the detection of IgG antibodies to hydatid cyst fluid-derived native or 
recombinant antigen B subunits, either in ELISA or in immunoblot formats (Wen and 
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Craig, 1994; Eckert and Deplazes, 2004). Studies on the hydatid cyst of E. 
granulosus have indicated the occurrence of high levels of host IgG heavy chain  
in the germinal layer of non-fertile cysts and suggests the host immune response 
could be destructive of protoscolex production by bringing about or causing 
apoptosis of the germinal membrane, possibly opening up an avenue for vaccination 
against established cyst (Blanton et al,1991 ; Lawn et al, 2004). 
 
Following the knowledge and understanding of the smallest size of the lipoprotein of  
antigen B to be 8KDa and believed to be Echinococcus specific with diagnostic  
potentials, Barbieri et al (1993) went on to prepare a mixture of lipoproteins antigens  
that contained the relevant diagnostic AgB and Ag5 from bovine hydatid cyst fluid by  
heparin- affinity chromatography. A standardized antigen mixture of high sensitivity  
and specificity for human hydatid serology has been provided by this heparin-  
binding lipoprotein fraction (HBLF) (Barbieri, et al, 1993; Barbieri, et al,1994).  
Although, a constant supply of parasite material is demanded by its preparation and  
there is the observation of false positive results with purified antigen. Fernandez et al  
(1996) in theoretically analysing how a mixture of recombinant proteins can help in  
solving the drawbacks observed and or obtained with the use of native antigens:  
production of unlimited amounts can be achieved under controlled conditions and it  
may be a possibility to identify and remove the cross- reactive epitopes without the  
loss of diagnostic sensitivity.  In search for recombinant proteins that would allow the  
preparation of antigenic mixture with such characteristics, Fernandez et al, (1996)  
screened an E. granulosus protoscolex cDNA library using a rabbit anti- HBLF serum  
and went further to describe the characterisation of a cDNA coding for an antigen  
similar to, but distinct from the already described 8-KDa subunit of AgB (Shepherd,  
et al, 1991; Frosch, et al, 1994). 
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The cDNA library prepared with E. granulosus protoscolices obtained from hydatid 
cysts of Uruguayan sheep were immunoscreened and allowed the isolation of a 
reactive phage clone (ʎ3C3) which was characterised further. Their results showed 
affinity- purified monospecific polyclonal antibodies against lambda 3C3 reacted by 
western blotting with HBLF bands of 8, 16, 24 and 32 KDa apparent molecular mass. 
Consequently, the pattern described as corresponding to AgB subunits (Lightowlers, 
et al, 1989) was reproduced with anti- ʎ3C3 antibodies. 
 
Recent research has demonstrated that AgB, encoded by a gene family constituted  
of member genes, exhibits variation to a very high degree (Frosch, et al, 1994;  
Chemale, et al, 2001; Arend, et al, 2004; Muzulin, et al, 2008). Five 8KDa subunit  
genes from E. granulosus so far have already being identified. They are named as  
EgB8/1, EgB8/2, EgB8/3, EgB8/4 and EgB8/5 (Haag, et al, 2004). EmB8/1-EmB8/5   
have also being identified in E. multilocularis (Mamuti, et al, 2006, 2007). AgB  
recombinant subunits were found to self assemble by Monteiro et al, (2007) into high  
molecular mass homo-oligomers with structural features that are similar to those of  
the parasite- produced AgB while they studied the recombinant subunits of AgB1,  
AgB2 and AgB3. 
 
Gene polymorphism, strain variability, differential expression and source of hosts are  
a few of many problems associated with the usage of AgB antigen in diagnosis  
(Jiang, et al, 2012). Therefore, the characterisation of AgB subunits immunologically  
is vital to the assessment of their actual diagnostic value. Majorly, and to date, the  
immunological studies on AgB subunits have focused mainly on AgB1 and AgB2  
(Rott et al, 2000; Virginio et al, 2003), the initially identified subunits. This study was  
carried out by Jiang Li et al, (2012) to clone and express all of the 5 identified subunit  
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genes of AgB antigen family, to investigate their serological reactivity and differences  
in the recognition of specific antibodies, to identify potential subunit antigens for  
immunodiagnostic tests and to proving a basis for standardization of AgB antigen. 
 
They (Jiang Li et al, 2012) analysed the reactivity of a panel of 243 serum samples  
from CE, AE, CC patients and NH with 8 recombinant subunit antigens by ELISA.  
They also made comparison of three paralogous subunits from E. granulosus  
(EgAgB1- EgAgB3) and E. multilocularis (EmAgB1-EmAgB3), respectively for their  
reactivities in CE and AE sera detection. Their results showed that all of the three  
orthologous subunits (EgAgB1 vs EmAgB1, EgAgB2 vs EmAgB2 and EgAgB3 vs  
EmAgB3) were not different statistically when detecting CE or AE sera and therefore  
suggested that there may be a similarity in their epitopes 
 
The diagnosis of lung hydatid disease is based on chest imaging using X-rays or  
computed tomography (CT). Serological tools are used only to confirm the diagnosis  
because of low sensitivity and incomplete specificity (Santivanez and Garcia, 2010). 
The assay performance is dependent mainly on the format of the test and nature of  
antigen used but can also vary according to the characteristics of the disease such  
as organs involved, number of cysts and presence of any cyst complications (Zhang  
et al, 2003; Zhang and McManus, 2006). Previously, the use of synthetic peptides or  
recombinant antigens derived from sequences of the two major components of cystic  
fluid antigen B (AgB) and Ag5 have been proposed for use as reproducible antigens  
to improve test reliability and allow better standardization (Ortona et al, 2000;  
Virginio et al, 2003; Carmena et al, 2006). 
 
The p176 antigen which is derived from AgB, is a 38-mer corresponding to the N- 
terminal extension of the subunit AgB8/1 (Gonzalez et al, 2000). Due to scarcity of  
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data on serological diagnosis of lung CHD and how published p176 studies do not  
allow estimations of its sensitivity or provide further details for pulmonary cases.  
Santivanez et al (2012) did a study and applied p176 ELISA in a series of known  
cases and responses of those patients were compared to the responses of   
noninfected controls to provide further information on the test performance of the  
assay for the diagnosis of lung CHD as well as its performance in relation to disease  
characteristics. The use of p176 was to counter the variability, high variability in  
results obtained with the use of cyst fluid as the antigenic source/ material. 
 
Results obtained for the sensitivity of the p176 ELISA for the diagnosis of lung CHD  
cases was almost 80%, despite the fact that the restricted numbers of samples with  
isolated pulmonary CHD prevented a more precise assessment of sensitivity. In the  
long run, the simpler, cheaper, semiquantitative ELISA format and the potential for  
better reproducibility make this ELISA a good alternative for the diagnosis and  
posttreatment follow-up of lung CHD. Diagnosis of infection in human is based on  
the identification of infiltrative or cystic lesions by imaging techniques such as  
ultrasonography or computed tomography (Brunetti et al, 2010). 
 
The diagnosis of AE is strengthened by immunodiagnostic tests such as ELISAs  
especially using native protoscolex or metacestode antigens, purified fractions (Em2  
antigen), or recombinant antigens (ІІ/3-10‾, Em10- or Em18- antigen) with variable  
sensitivities and specificities (Gottstein, et al, 1993; Brunetti, et al, 2010; Schweiger,  
et al, 2011). The study undertaken by Barth et al (2012) was to validate the  
immunohistochemical diagnosis of AE using the monoclonal antibody mAb Em2G11  
on a large number of paraffin embedded samples from resection specimens and  
from cutting needle biopsies and fine needle aspirates of patients with AE or CE that  
have been confirmed histologically or with putative diagnosis. An epitope of a mucin- 
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type carbohydrate antigen called Em2 (Hulsmeier et al, 2002) which is a major  
antigen of the laminated layer of the E. multilocularis metacestode that is also  
present in the cyst fluid (Deplazes and Gottstein, 1991; Gottstein et al, 1992) is  
recognised by the monoclonal antibody mAb Em2 G11. 
 
Barth et al (2012) were able to show that the mAb Em2 G11 is strongly positive in  
the laminated layer of E. multilocularis lesions in various human tissues in all  
samples studied. According to them, no protoscolices were found in all investigated  
material of 49 AE patients which confirmed protoscolices are a very inconstant  
diagnostic feature (Marty et al, 2000), and therefore submitted that the mAb Em2  
G11- positive laminated layer is the crucial immunohistological hallmark for diagnosis  
of AE. The mAb Em2 G11 is also said to be species specific as no positive results  
were recorded at all for CE neither in the laminated layer, germinal layer, calcareous  
corpuscles nor in the protoscolices when stained with mAb Em2 G11 (Barth et al,  
2012). 
 
 
1.11    Treatment 
In endemic regions, asymptomatic hepatic cystic echinococcosis are common and 
up to 75% of infected people may remain free of symptoms for more than 10years 
(Frider et al,1999). ―Cysts may be seen to expand, become septate, or calcify when 
patients are monitored with serial ultrasound‖. A greater occurrence of this condition 
have been identified in community studies with screening ultrasound compared to 
similar studies of patients presenting for medical attention (Larrieu and Frider, 2001). 
In spite of advances in chemotherapy, surgery still remains the main choice of 
treatment for hepatic CE (WHO-IWGE, 1996), and the increasing use of 
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percutaneous aspiration (Filice et al, 1990; Wang et al, 1994 ; Akhan, et al, 1996 ; 
WHO/OIE, 2001). 
The possibility of cyst recurrence however remains the main problem with this form 
of treatment. Recurrence rates of cyst after surgery have been reported as being 
between 2% and 20% (WHO/OIE, 2001). However, these rates may be subjected to 
some level of inaccuracy since occurrence of cysts in patients after surgery could 
also be because it had been missed in the initial examination or because of 
subsequent reinfection after exposure to eggs. In establishing and validating whether 
cysts are truly recurrent after surgery or have by other means arisen, the use of 
ultrasound based cyst morphology could also be of benefit (Wang et al, 2003). 
 
Surgical removal of the lesions is included in the treatment options for CE, and CE in 
most parts of the world is the most common reason for abdominal surgery. Ninety 
percent success rate has been attributed to surgery (Pawlowski et al, 2001). The 
PAIR (Puncture-Aspiration-Injection- Reaspiration) technique is an alternative to  
surgery (WHO/OIE, 1996). Chemotherapy, with drugs such as benzimidazoles, have 
also been used with some success. An indication for a wait and see approach to 
treatment is employed in calcified cysts (Torgerson and Budke, 2003). 
 
 
1.11.1 Surgery 
The principal and mainstay therapy for large cysts, infected cysts, those that are 
superficial and likely to rupture, and those in vital and anatomical sites or exerting 
considerable and substantial mass effect has always been surgery. ―Surgical options 
include: pericystectomy, partial hepatectomy or lobectomy, open cystectomy (with or 
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without omentoplasty), or (palliative) tube drainage of infected cysts. Cyst extrusion 
(Barrett‘s technique) is also a surgical option for pulmonary disease‖. More radical 
surgery is associated with a higher complication rate but also a lower relapse rate. 
Recurrence usually is due to either insufficient cyst removal or previously undetected 
cysts. Percentage of reported recurrence rates range from 2-25% (Ammann and 
Eckert, 1996). 
 
 
1.11.2   Pair 
The puncture, aspiration, injection, reaspiration (PAIR) technique was introduced in 
the mid-190‘s (Gargouri et al,1990; Filice and Brunetti, 1997). Under ultrasound 
guidance, the cyst is punctured, as much cyst fluid is aspirated as possible, followed 
by the injection of a protoscolicide (e.g, 95% ethanol), and cyst contents reaspirated 
between 15-20mins later. This technique should only be undertaken by skilled 
practitioners, with intensive- care support on ground in the event of anaphylaxis.  
Assessment should be made of cyst aspirates for the presence of protoscolices or 
bilirubin. The use of PAIR should only be in, or, with patients with chemotherapeutic 
cover so as to minimise the risk of secondary cystic echinococcosis. This technique 
has not been performed or experienced with children and or pregnant women. 
 
The use of PAIR is best for liver cysts that are 5cm or of greater diameter that 
anechoic (echoless), multiple or multiseptate. The PAIR technique has also been 
used in patients who have relapsed after surgery. For cysts that are superficial or not 
accessible, and  for cysts that are solid, calcified or communicate with the bile ducts,  
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PAIR is inadvisable (Anonymous, 1996). Percentage rates of complication ranges 
from 28% in the absence of albendazole (Men et al, 1999), to 5-10% with 
concomitant chemotherapy (Pelaez et al, 2000 ; Aygun et al,2001). 
 
―A multicentre survey on PAIR carried out by the WHO informal working group on 
echinococcosis (Filice et al, 2000), reported a 1% major complication (anaphylaxis or 
spillage) rate and a 13.7% minor (fever, rash, cyst infection, or haemorrhage)‖. 
―The usage of PAIR with albendazole chemotherapy has been shown to be as 
effective as pericystectomy for hepatic cystic echinococcosis in one randomised 
propective trial (Khuroo et al., 1997) with lower post-procedure morbidity and shorter 
hospital stay. 
 
 
1.11.3   Chemotherapy 
Albendazole and mebendazole, the benzimidazole compounds have been the 
bedrock, the fundamental chemotherapy for cystic echinococcosis. ―Treatment with 
albendazole (10mg/kg in divided doses – usually 400mg – twice daily) results in the 
disappearance of up to 48% of cysts and a substantial reduction in size of a further 
24%‖ (Horton, 1997). Mebendazole (40-50mg/kg per day in three divided doses) is 
less capable of producing desired effect than albendazole. (Horton, 1997). 
 
Due to the limitation on toxicological data, the administration of albendazole was 
originally done in three to six 4-week cycles with intervals of 14days. However, more 
recent data have suggested that equivalent or improved efficacy with no increased 
adverse effect is achieved by continuous treatment (Liu, 1997; Franchi et al, 1999). 
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―Non-viability of cyst increases with duration of treatment – from 72% of cysts non-
viable after 1 month to 94% of cysts non-viable after 3 months of treatment‖ (Gil-
Grande et al, 1993), with the usual adverse effects including nausea, hepatotoxicity, 
neutropenia (which may not be reversible), and alopecia (occasionally). 
 
All patients are advised to have regular monitoring of leucocyte counts and liver 
function tests. The protoscolicidal metabolite of albendazole is albendazole sulphide. 
Praziquantel (25mg/kg per day) has been used concurrently with albendazole for 
concomitant treatment of cystic echinococcosis, and early trial in man has shown  
improved efficacy over albendazole alone (Mohamed et al,1998). ―Albendazole and 
mebendazole are listed as category C drugs in pregnancy in the USA (Gilbert et al, 
2001), and category D and B£ respectively in Australia (Anonymous, 2000). Neither 
drug is definitely inadvised in pregnancy. Specialist advice should be sought if 
treatment during pregnancy is likely‖. 
 
 
1.12   Changes in Cyst Morphology and Follow Up After Treatment. 
The potential success of treatment can be followed up using ultrasound or CT 
scanning. Morphological changes are shown by a significant number of cysts with 
chemotherapy and PAIR (Morris et al, 1984; Filice et al, 1992; Nahmias et al, 1994; 
Filice and Brunetti, 1997), but also, there is evidence that, cyst structure even in 
untreated people can change and cysts disappearance can happen in time without 
any intervention (Romig et al, 1986; Morris, 1986; Pawlowski 1997; Wang et al, 
2003; Wang et al, 2006). 
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Every cyst begins as a typical small unilocular cyst with clear cyst fluid. In some 
cases, the cyst is termed to be sterile as no further development takes place. While 
in most other cases, there is subsequent development of protoscolices within the 
brood capsules attached to the germinal layer. ―For many cysts, change from this 
form is not experienced, and ultrasound examination can show growth of the cyst but 
no change in internal structure over several years‖ (Rogan et al, 2006). Other cysts 
show a significant level of variation in internal structure, such as calcification, 
collapsed cyst walls and the presence of additional daughter cysts internally. 
Exhibition of such heterogeneity in cyst structure has for clinicians been an issue in  
terms of how to treat CE. The presence of daughter cysts, could be an indication that 
PAIR is a less favourable option; a distinct, small, unilocular cyst might give a good 
response to chemotherapy, while a small, calcified cyst might signify poor parasite 
viability and a good prognosis and would thus be a candidate for long term 
observation only (Pawlowski, 1997). 
 
 
1.13 Cyst classification 
A number of CE classifications have been proposed in the last 20years based on the 
appearance of the ultrasound images, with the most recent by WHO (Gharbi et al, 
1981; Lewall and McCorkell, 1985 ; Caremani et al, 1997 ; WHO/OIE, 2001). The 
first, most enduring and lasting attempt to characterize human CE by ultrasound was 
by Gharbi (Gharbi et al, 1981) Gharbi based his classification largely on the 
sonographical analysis of the morphology and structure of hepatic hydatid cysts in  
121 CE cases that were confirmed by surgery. Five categories to indicate CE 
pathological cyst types were proposed by Gharbi: ― Type 1, pure fluid collection, 
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Type 2, fluid collection with a split wall, Type 3, fluid collection with septa, Type 4, 
heterogenous echo patterns, and Type 5, presence of reflecting thick walls indicative 
of calcification‖ (Gharbi et al, 1981 ; Wang et al, 2003). 
 
Gharbi‘s classification was the basis, foundation for all subsequent ultrasound 
classifications, which included largely minor modifications and or additional 
categories. Fifty nine clinical CE cases formed the basis of Lewall and McCorkell‘s 
CE classification and 3 categories were proposed by them. Type 1, simple fluid-filled 
cysts; Type IR, lesions containing wavy membranes, representing detached 
endocyst secondary to rupture; Type 2, lesions contained of daughter cysts and/ or a  
formed echogenic material; and Type 3, dead, densely calcified lesions (Lewall and 
McCorkell, 1985). 
 
The 7 categories of CE classification proposed by Caremani were based on 113 CE 
cases which included many asymptomatics detected in Italy. ―Type 1, simple CE, 
which was further divided into 1a and 1b, with (1a), being echo-free and or (1b), with 
fine echoes; Type 2, multiple CE, also sub-divided into 2a and 2b, (2a) being a 
multiple contiguous and or (2b) being multiseptated with rosette, honeycomb and 
wheel-like pattern; Type 3, with detachment of endocyst CE, is also sub-divided into 
(3a), with double layer image or, (3b), with water-lily sign; Type 4, mixed type CE, 
with fluid and solid aspect; Type 5, heterogenous CE, sub-divided into (5a), with ball 
of wool pattern or, (5b), with hypoechogenic image; Type 6, hyperechoic CE, (6a), 
being with snow-storm pattern or, (6b), with dyshomogenous aspect; and Type 7, 
calcified CE, (7a), with advanced calcification of the layer only or, (7b), with 
calcification of overall cyst (Caremani, et al., 1997). 
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With the use of ultrasound morphology to monitor cyst development or regression on 
the increase, a more universal classification was considered necessary. With this 
aim, the WHO Informal Working Group on Echinococcosis (WHO-IWGE) proposed 
recently a standardized classification to bring about the unification and simplification 
of the various ultrasound CE classifications (WHO/OIE, 2001).Six categories were 
proposed by WHO-IWGE: ―Type CL, unilocular cystic lesion(s) with uniform anechoic 
content, with pathognomic signs that is inclusive of visible cyst wall and ―snowflake‖ 
signs; Type CE2, is a multivesicular, and multiseptated cysts; Type CE3, anechoic 
content with a detached laminated membrane from the cyst wall visible as a floating 
membrane or as a ―water lily‖; Type CE4, hyperechoicheterogenous, or hyperechoic 
degenerative contents, daughter cysts not present; and Type CE5, are cysts that are 
distinctive by thick calcified wall that is arch-shaped, giving a cone-shaped shadow, 
variation in the degree of calcification may be from partial to complete. Also included 
in the WHO-IWGE standardized ultrasound classification of CE are the size and  
biological status of the hydatid cyst(s). In summary, cyst size ‹5cm is classified as 
small (s), medium/middle (m) size is from 5-10cm, and ›10cm is large (L). Biological 
status also should be classified as ―active‖ (which comprises of group 1: Types CE1 
and CE2), ―transitional‖ (these are group 2: Type CE3), or ―inactive‖ (comprising of 
group 3: Types CE4 and CE5) (WHO/OIE, 2001). This classification for CE by WHO 
is yet to be applied in many clinical situations or mass screening programmes (Wang 
et al,2003). Although being able to classify cysts on the basis of their morphology in 
order to perform surgery is important, it is equally important that the classification 
gives some indication of developmental or degenerative changes in the cyst that has 
either occurred naturally or after therapy. Detachment of the laminated layer from the 
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ectocyst, presence of daughter cysts and cyst calcification have all been highlighted 
by all of the proposed classifications, these may be considered as regressive signs 
though not consequently indicating total cyst non-viablity. 
 
However, there is significant discussion on the possible sequential nature of these 
morphological changes. Largely, this is associated to the sequence of events 
surrounding daughter cyst formation. Cysts with a detached laminated layer have 
been classified by Gharbi as Type 2, and those with daughter cysts as Type 3. This 
order was reversed by the Caremani system and the WHO classification classifying 
cysts with daughter cysts as Type 2 and those with detached laminated layer as 
Type 3 (Wang et al, 2003). Pawlowski, 1997 has suggested that in some cases 
changes in cyst morphology may represent a natural progression or a natural history 
in addition to the morphology of cyst being useful, important, vital, and significant in 
planning surgical intervention or chemotherapy. There have also been recorded 
cases where hydatid cysts naturally disappear over a long period of time (Romig et 
al, 1986). It is therefore vital that developmental succession of cyst structure is 
reflected in the ultrasound classification (Wang et al, 2003).An international 
classification of ultrasound images of cystic echinococcosis which should in principle 
is used whenever ultrasound diagnosis is done has been produced by the WHO 
expert group on echinococcosis (WHO/IWGE, 2003). In addition, laboratory-based 
diagnosis can provide a useful confirmation of clinical infection and can also be 
applied to aid epidemiological surveys of cystic and alveolar echinococcosis in 
endemic regions. 
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The Current Classification System of Cystic Echinococcosis Cysts 
(WHO/IWGE,2003) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Classification of ultrasound images. 
CE1-CE2 cyst types are considered fully viable, CE3 cyst type is considered and classified a 
transitional stage, and may remain viable or regress to a non-viable stage; CE4-CE5 are 
degenerative , non-viable and usually inactive stages. 
 
 
1.14   Natural History of Hydatid Cyst 
A change in morphology might or might not be noticed in cysts over a relatively long 
period of time in treated or untreated individuals. Distinctly, slow degenerative 
changes are shown by some hydatid cyst and have a natural history or evolution. 
The details of changes are less well defined and have nonetheless been addressed 
by several authors (Pawlowski, 1997; Daeki et al, 2000; Teggi and Di Vico, 2001). 
CE4-hyperechoic contents, with degenerating 
membranes  
Status: inactive, and mostly non-fertile. 
CE5- thick calcified cyst wall ,causing a cone 
shaped shadow.   
Status: inactive. 
CL   CE1 
 
 
CE2   CE3 
 
CE4   CE5 
 
CL- small unilocular cystic lesion with clear 
(anechoic) fluid and no visible cyst wall.   
CE1- unilocular cysts with anechoic content and 
visible cyst wall. Status: active. 
 
CE2-multivesicular cysts round/oval with visible 
wall.   
 Status: active. 
CE3-unilocular cyst, may contain DC, anechoic 
content with cyst wall visible as floating 
membrane.   
Status: transitional and active. 
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―The most recent interpretation is based on the current WHO classification as a 
progressive natural history of cyst development from CE1 to CE5‖ (Macpherson et 
al,2004). It is enormously important to understand the possible developmental fate of 
a cyst, to make possible the monitoring and prediction of disease progression, 
regression and recurrence (Rogan et al, 2006). 
 
However, there is some debate and controversy as to whether the WHO progression 
is too simplified, and alternative classifications have been suggested by some 
authors that would also relate to size of cysts and indicate a different order of events 
(Wang et al, 2003).Follow up of cases can be for as long as 8-10years after 
treatment, but there is huge variation between studies in respect to monitoring 
points, making comparisons difficult. Therefore, it might not be completely as to what 
stages a cyst has passed through between scans (Rogan et al, 2006). Based on 
several literature descriptions, it appears that several developmental pathways can 
come from a typical unilocular CE1 cyst (Wang et al, 2003; Teggi and Di Vico, 2001). 
The viability of the parasite tissues within the cyst is the important feature; the cyst  
has the ability to regenerate in some form if viable portions of germinal layer, brood 
capsule wall or protoscolices are present. Usually, CE1 cysts are viable and fertile 
(possessing protoscolices), while CE5 cysts are dead and calcified (Rogan et al, 
2006). The remaining types and their viability are more questionable.  
 
Discussions mostly have revolved around the Type CE2 cysts (with daughter cysts) 
and the Type CE3 cysts (with collapsing cyst walls). The CE3 type of cysts are being 
accepted as transitional, showing degeneration as a result of the observed collapse 
of the cyst wall, although some parasite tissues that are viable could still be 
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contained, as demonstrated by some cases that had reverted to type CE1 (Larrieu et 
al,2004).CE2 cyst types are classified as active and are not accepted generally as 
showing degeneration. Viability of the parasitic material of the daughter cyst is not 
questionable, but the viability of the primary cyst is, and this is important when the 
natural history is being considered (Rogan et al, 2006). 
 
The lack of understanding of the origin of daughter cysts is a main problem, as there 
is no histological support for the assumption that these arise from the germinal layer. 
This interpretation has come under arguments based on ultrasound images that 
seem to show a series of progressively larger daughter cysts forming around the 
periphery of the primary cyst. It is however impossible to say that the cysts have 
arisen from the intact germinal layer from these images given that the germinal layer 
is less than 1mm thick (Rogan et al, 2006). In addition, the internal production of a  
laminated layer would not be allowed due to the polarity and orientation of the 
tissues within the germinal layer (Bortoletti and Ferretti, 1978). The relevance of this 
is particularly with those ultrasound studies that conspicuously show formation of 
daughter cysts by internal growth, endogenous proliferation of the germinal layer 
(Czermark et al., 2001).  A vesicle, in these cases seen forming from the mother cyst 
wall would have the laminated layer on the inside and the germinal layer on the 
outside, which according to Rogan et al., (2006), is incorrect. 
―The contrasting argument is that daughter cysts arise from fragments of ―disrupted‖ 
germinal layer or other parasite tissues‖ (Rogan et al, 2006). The capability and 
ability to form miniature hydatid cysts in vitro have been shown by the brood capsule, 
wall, the protoscolex attachment stalk and or the protoscolex itself (Smyth and 
Barrett, 1980; Rogan and Richards, 1986). The greatest ability to differentiate into 
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hydatid cysts is possessed by protoscolices and is directly involved with causing 
secondary hydatidosis, and altered physiological conditions can trigger cystic 
differentiation of protoscolices in vitro (Smyth and Barrett, 1980). Studies have also 
shown direct evidence from cysts in livestock that protoscolices show cystic 
development within degenerate primary cysts (Rogan, 1988).  Although, the 
appearance of the fluid within daughter cysts is usually anechoic (clear), the fluid  
within the primary cyst is often more hyperechoic (dense), which signifies the 
presence of some sort of debris or infiltrate (Rogan et al, 2006). This material was 
referred to as ―matrix‖ by Lewall and McCorkell (Lewall and McCorkell, 1985) and 
cysts such as this are often full of pus or leucocyte infiltrate at surgery and debris 
from a degenerate primary cyst (Abu-Eshy, 1998; Teggi and Di Vico, 2001). Bacterial 
infection, although not always, is sometimes present (Schipper et al, 2002). It is clear 
that the germinal layer and the cyst wall cannot be intact if cellular infiltrate or 
bacterial cells are present in the cyst cavity, therefore, the formation of daughter 
cysts is involved with damage or primary cyst degeneration (Rogan, 1988; Teggi and 
Di Vico, 2001; Wang et al, 2003). 
 
 
1.15 The Role of Cytokines in Echinococcosis 
In regards to the investigation of cytokine production in AE and CE patients, several 
studies have been undertaken to determine the underlying immunological responses 
to infection and disease. Much of the current understanding of Echinococcus 
infections have resulted from murine studies because of the difficulty in studying 
early-stage infection in humans. Nonetheless, it is generally obvious from these 
investigations that the onset of infection is biphasic, with an early predominant 
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induction of a Th1 response, recruiting Th1 cytokines such as IFN-γ (Mourglia-Ettlin 
et. al, 2011), which then switches to a Th2 response, predominantly inducing IL-4, 
IL-5, IL-10, and IL-13, in chronic and progressive disease stages, bringing about the 
hallmark response characteristics of most helminthic infections (Rogan, 1998; 
Mourglia-Ettlin et. al, 2011). Degenerating cysts in murine models are by contrast 
associated with Th1 cell activity and the production of IFN-γ (Rogan, 1998) which 
shows the protective effect of Th1 cytokines during infection and disease. Even 
though immunological studies of early infections are more difficult in human 
populations, according to data available from epidemiology studies by Yang et. al, 
(2009); Vuitton, (2003) have shown that different cytokine profiles are displayed by  
natural courses of human AE and CE at different stages of disease progression.  
 
Hypotheses have been made that Th1 type response is associated with the very 
early stages of infection, while Th2 cell activity is more associated with active 
disease and a poor response to chemotherapy, thereby giving support to murine 
study findings that class switching occurs between Th profiles (Mourglia-Ettlin et. al,  
2011). The ability of the Echinococcus parasites to stimulate Th2 cytokines have 
been shown by several studies to be antigen-specific, thereby indicating that the 
parasite stage plays a vital role in the Th1/Th2 paradigm. Particularly, antigen B 
(AgB) has been shown to hugely contribute to this Th2 polarization (Rigano et. al., 
2001). In addition, the immune response is dose-dependent, so that the higher the 
antigen dose, the greater the Th2 response. This is in consistency with disease 
progression in humans-wherewith increased antigen levels are produced by 
metacestode development, which in turn brings about a greater shift in the Th2 
response, furthermore protecting the parasite.  
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However, following successful drug treatment with albendazole, the polarized Th2 
response in advanced disease tend to revert back to Th1 (Rigano et. al, 1995; 
Rigano et. al, 1999). It is important to note that both Th1 and Th2 cytokines are 
produced in patients with active and/ or progressive disease; nonetheless, it is only 
those patients who are able to elicit a Th1 response that have been shown to 
respond well to chemotherapy, where patients maintaining higher levels of IL-4 and 
IL-10 do not (Rigano et. al, 1995; Rigano et. al, 1995; Rigano et. al, 1999; Rigano et. 
al, 1999).A Th1 profile also correlates well with good prognosis in patients following 
the removal of cysts surgically and in those with inactive, late-stage of CE5 cysts 
(Rigano et. al, 2004; Rigano et. al, 2004). An Algerian study of 177 patients with CE  
showed that the Th1/Th2 skew is correlated and related to clinical stage, disease 
progression and prognosis, with Th1 cytokine being associated with protection and 
susceptibility to disease associated with Th2 (Mezioug and Touil-Boukoffa, 2009). 
The ability of the patient to maintain a Th1 response or yield to a Th2 response 
eventually decides whether he/she is vulnerable or resistant to disease and respond  
successfully to treatment (YuRong, et. al, 2012). 
 
Early antibody production is thought to be most essential for the development of 
resistance to infection (Dempster, et. al, 1992). During early infection, an increase in 
antigen- specific IgG production is indeed observed, which is thought to trigger 
down-stream responses including the production of cytokine. Even though there is 
little understanding about early infection, given the expressed difficulty in early 
diagnosis of the disease, IgG1, IgG4, IgE and IgM are dominant in patients with 
chronic disease, but relatively low levels are attained by these isotypes in patients 
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with inactive or regressive disease (Craig, 1986; Daeki et. al, 2000; Khabiri et. al, 
2006).Contrastingly, levels of IgG2 and IgG3 become elevated when cysts become 
infiltrated and/ or destroyed by the host (Daeki et. al, 2006), during which time clearly 
noticeable decreased levels of IgG1 and IgG4 are observed (Bayraktar, et. al, 2005).  
In murine studies of both AE and CE, antibody titers were found to be comparatively  
consistent in affected mice, notwithstanding the susceptibility of the host strains 
(Vuitton et. al, 2006), but changes according to the severity of the infection were 
observed (Vuitton et. al, 2006). This is in line, in consistency with the natural growth 
of cysts of both E. multilocularis and E. granulosus where protection against the 
immune response is provided by the intact cyst wall. 
 
Nevertheless, for E. granulosus, where growth is rapid or where the cyst becomes 
excessively large, rupture may occur bringing about the rapid recruitment of host 
antibodies in response to antigen B, particularly isotypes of IgG2 and IgG3, which 
are capable of damaging cystic germinal membranes, giving rise to the killing of 
protoscolices and cyst degeneration (Siracusano et. al, 2008). Subsequent to the  
establishment of an AE infection, the acellular laminated layer (LL) of the parasite 
lesion, which is characterized by its rich high molecular-weight polysaccharide 
composition- with the mucin-type glycosylated Em2 protein antigen being a major 
component (Dai et. al, 2001), is capable of restricting the physical exposure of the 
germinal layer to the host immune system and bring about the production of low-
avidity IgG isotypes. It is known that parasite antigens trigger antibody production, 
particularly antigen B, which excite the production of IL-4 and IL-13 and suppress the 
Th1 response through polyclonal antibody incitement (Rigano et. al, 2001; Mourglia-
Ettlin et. al, 2011). Several studies, both in mice and humans have shown that Th1 
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cytokines, mostly IFN-γ, are well correlated with IgG2 levels and disease 
progression. Consequently, useful markers or indicators of disease activity and of 
the natural course of disease/cyst development can be provided by measuring 
cytokine and antibody profiles, particularly the IgG subclasses (Rigano et. al, 1995; 
Vuitton, 1997; Daeki et. al, 2000).  
 
An indication to whether a patient would respond to treatment or not may also is 
offered by these immune profiles. Regardless of this, there remains a substantial 
variance in the immunological response between patients that may be affected by 
the parasite strain and/ or antigen type produced, which influences the development 
of T helper subsets. Antigen dose and the genetic background of the host are other 
factors that may also contribute (Emery et al, 1997; Eiermann et. al, 1998). 
Contributing significantly also is the general well- being and health of an individual to 
disease susceptibility and this is especially influenced by conditions underlying such 
as malnutrition and/ or coinfections with tuberculosis (Vuitton, 2003) or HIV (Sailer et 
al, 1997; Wellinghausen et. al, 1999; Zingg et. al, 2004). 
 
 
1.16  POST-TREATMENT FOLLOW-UP 
The pre-requisite for the evaluation of failure or success of curing disease is the 
long-term post-operative treatment and serological surveillance. Surgery still is the 
main treatment of hydatid cyst, even though chemotherapy may be used in some 
cases (El-On, 2003; Kern, 2003). There has been more than 30% reported cases of 
local recurrence or secondary infection during surgery (Rafiei et. al,2008). Also, 
during chemotherapy, progress of treatment is difficult to ascertain. Consequently, 
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monitoring of CE patients after surgery and during chemotherapy has been  
emphasized. Despite limitations encountered with serological tests, due to their cost 
effectiveness and improvement facilities, they are probably best choice for follow-up 
assessment of CE after either surgery and / or chemotherapy (Rafiei et. al, 2008). 
 
Serological diagnosis in a routine laboratory depends mainly on the detection of 
immunoglobulin class G (IgG) antibodies directed against different antigens of E. 
granulosus or E. multilocularis (Grimm et. al,1998). Sensitivity and specificity of the 
serological tests depend on the stage of the disease, the localization of the 
parasites, the antigens, and the techniques used (Gottstein, 1992; Craig, 1993). One 
of the most widely used antigens is the cyst fluid (CF) of E. granulosus cysts of 
sheep or cattle origin, and the enzyme-linked immunosorbent assay (ELISA) is one 
of the most commonly used techniques in serodiagnostic laboratories.In cases of CE 
of the liver, antibodies against CF antigens can be detected with a high diagnostic 
sensitivity by this method (Grimm, et. al., 1998). 
 
 
 
Rationale of study 
To date, most of the work carried out on CE has been in serological diagnostic 
testing involving antigens derived from HCF and more recently, molecular 
techniques such as the PCR. Also, imaging techniques have been used to date in 
the classification of cyst types. There has not been so much done with regards to 
serological classification of cysts before treatment and in the area of follow-up after 
treatment using antigens other than the native hydatid cyst fluid (HCF) and purified 
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antigen B (AgB). To bring about the development of a means of measuring the 
immunogenic activity in sera of CE patients using antigenic markers, which, may 
potentially create antigen/ antibody profiles signalling the progression or regression 
of disease in relation to/ with particular categories of cyst. 
 
The use of these markers in association with IgG subclasses may bring out and 
reveal information distinctively, with emphasis particularly on the development of a 
more specific means of monitoring success or failure of therapy during post-
treatment, follow-up and surveillance. Studies by Doiz et. al, (2001) showed that 
antibodies from CE patients with specific proteins of molecular weights 39KDa and  
42KDa from the antigen B/5 rich fraction of HCF by western blot analysis may be  
useful in the status of the disease, as these bands were present in patients with 
progressive disease, but absent in cured patients. 
 
The use of western blot with a purified antigen was analyzed by Doiz et al,(2001), so 
as to evaluate and determine its possible application in post-treatment monitoring. 
Following their purification procedure, they were provided with proteins of the 
following molecular weights 12-14, 16, 20, 24-26, 34, 39 and 42KDa and went on to 
prove that the western blot technique  shows a disappearance of the bands in the 
case of cures, as well as persistence  and appearance of new bands in the opposite 
case. In the usage of antigens other than HCF and antigen B, little work has been 
done. However, a recent work by Taherkhani et al,(2007) has shown that a 
significant proportion of hydatid patients recognised extracts of sheep hydatid cyst 
laminated layer containing proteins of low molecular weights. 
 
58 
 
The aim of this study is to investigate the recognition of crude antigens by sera of 
patients of confirmed hydatid disease of different cyst types and stages in relation to 
their reactivity with whole immunoglobulin (IgG) and IgG subclasses 1 and 4 in an 
attempt to identify, classify and determine disease categorisation using 
immunological markers. 
The objective of the current study is to classify the laminated layer of Echinococcus 
granulosus using different immunological methods with a view to using it as an 
antigenic material in studies involving the diagnosis of hydatid disease and follow-up 
after treatment. 
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CHAPTER 2    
MATERIALS and METHODS 
2.1    Antigenic Materials 
2.1.1 Hydatid Cyst Fluid (HCF) 
 Liver and lung of infected sheep were collected from a local UK abattoir brought 
back to the laboratory at University of Salford. Carefully, cysts were removed, 
aspirated and antigen or hydatid cyst fluids were collected according to the method 
described by Rogan et. al, (1991). A brief description, hydatid cysts were aseptically 
aspirated using sterile 5ml syringe and needle, the fluid was centrifuged and the 
supernatant obtained was used as the crude hydatid cyst fluid and this was put in 
sterile 50ml bottle and stored at -20℃ until use. 
2.1.2     Laminated Layer (LL) 
The laminated layer was prepared as described by Taherkhani et. al, (2007). The 
laminated layer was carefully removed from the whole cyst under magnifying 
microscope using forceps and scapels. After which the parasite layer was kept 
frozen, and then thawed and cut into 1cm strips, put in 1ml PBS and freeze-thawed 
twice. Upon thawing, the laminated layer was weighed, and for the purpose of this 
study 17g was used. The strips were cut into smaller pieces and ground to a pulp 
using mortar and pestle. The mixture, i.e.17g of laminated layer and 17mls of 10% 
PBS was transferred into a plastic beaker, put on ice, and sonicated in a 150W 
sonicator for 2minutes at 10secs on and 10secs off cycle. The resultant milky-like 
liquid was transferred to sterile 1.5ml eppendof tubes and centrifuged at 10,000 rpm 
for 15mins. The supernatant was transferred to new sterile tubes and stored at -20℃ 
until use. 
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2.2 Sera.  
Serum samples used for the purpose of this current study were collected as part of 
the African Medical and Research Foundation (AMREF) Hydatid Control 
Programme, based in Lokichoggio, Kenya under the management of Dr Eberhard 
Zeyhle. Collection of many of the samples was made over a long period of time, but 
all samples were stored at -20°C without repetitive freeze thaw. Each patients 
diagnosis was confirmed at AMREF by the using ultrasound examination. Each 
patient was monitored at regular intervals by ultrasound and details of cyst size and 
morphology recorded by photographs and notes. The classification of cyst types 
observed was based on matching the ultrasonographers‘ notes to the WHO 2003 
classification system under the guidance of Dr Zeyhle. Serum samples were taken at 
each observation point. Most patients were put on a schedule to take one or more 
courses of albendazole at 20mg/kg/day (see Table 2.1). Some patients experienced 
a delay before their first course of albendazole was taken and these could be 
regarded as ―untreated‖ for the preliminary part of their observation. Treatment was 
refused by some other patients and these also were regarded as untreated. 
Several hundred serum samples from 45 confirmed hydatid patients in total were 
supplied by AMREF. These samples had not been sorted into any order at the 
beginning of the current study. In order to select panels of sera that are usable, a 
database of patient details and clinical (ultrasound) information was established 
using data collected at AMREF. Serum samples matching the clinical data were then 
identified comprising 22 patients who had undergone treatment and who had 
continuous sampling times, and 9 untreated patients. 
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For optimisation pourposes of the crude antigen ELISA assays and analyses of CE 
patients sera, negative controls comprised a pool of normal sera from a CE endemic 
area (Turkana, Kenya). For Western blot analysis and ELISA detection of total serum 
IgG and IgG subclass antibodies from the sera of infected individuals probed, normal 
human sera was used for negative controls (Sigma-Aldrich, UK). 
 
 
Table 2.1 Summary of Patient Information 
Patient 
ID 
Gender/ 
Age 
Cyst 
series 
Organ 
Involvement 
ALB 
Chemotherapy 
(mg/kg body 
weight)/ 
surgery 
Sera 
Timeline 
B142 Female 
6 
CE1, 
CE4 
R/ liver Untreated 0-
42.7months 
P160 Female 
16 
CE2, 
CE3 
R/ liver Untreated 0-
33.9months 
X345 Female 
20 
CE2, 
CE3 
Omentum/ 
mesentery 
Untreated 0-3.6months 
X161 Female 
17 
CE3, 
CE4 
R/ liver 27.6mths ALB 
(20mg). 
0-
31.6months 
Y88 Female 
5 
CE1 R/ liver 4.8mths 2 
courses ALB 
(20mg); 
17.8mths ALB 
(20mg). 
0-8.4months 
Y13 Female 
20 
CE1, 
CE3, 
CE4, 
CE5 
R/ liver, lower 
abdomen 
3.8mths 3 
courses ALB 
(20mg); 
22.2mths ALB 
(20mg); 
58.7mths ALB 
(20mg); 
62.3mths 
endocystectomy
. 
0-
209.8month
s 
Y28 Female CE1, R/ liver 5.5mths 3 0-
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20 CE3 courses ALB 
(20mg); 
41.6mths 
cystectomy and 
2 courses ALB 
(20mg). 
46.9months 
Y51 Female 
10 
CE1, 
CE3, 
CE4 
R and L/liver, 
Omentum/mesente
ry 
1.6mths 1 
course ALB 
(20mg). 
0-
10.5months 
X269 Female  Data  
not 
availabl
e 
Kidney Untreated Data not 
available 
Y63 Female 
25 
CE1, 
CE3 
R/ liver At point ―0‖ 1 
course ALB 
(20mg). 
0-
47.3months 
Y179 Female 
22 
CE2, 
CE£ 
R/ liver 0.1mths 3 
courses ALB 
(20mg); 
15.1mths ALB 
(20mg); 
23.9mths ALB 
(20mg). 
0-
42.7months 
Y235 Female 
46 
CE2, 
CE3 
R/ liver 2.2mths ALB 
(20mg). 
0-6.2months 
Y111 Female 
30 
CE1, 
CE2, 
CE4 
R and L/ liver 0.1mths 3 
courses ALB 
(20mg); 
15.1mths ALB 
(20mg); 
23.9mths ALB 
(20mg). 
0-
46.2months 
156 Female 
33 
CE2 R and L/ liver, 
Omentum/ 
mesentery 
1.8mths 2 
courses ALB 
(20mg); 4.2mths 
had 
endocystectomy
. 
0-4.1months 
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2.3 Enzyme-Linked Immunosorbent Assay (ELISA) 
The enzyme-linked immunosorbent assay (ELISA) was performed following 
previously standardized ELISA protocols by Rogan, (1997). The pooled positive and 
negative human serum was tested for Echinococcusgranulosusantigens.  Optimum 
antigen concentration and dilutions were pre-determined by checkerboard titration, 
and an antigen concentration and dilution of 1:100 (1ml of antigen and 9ml of 
Bicarbonate carbonate buffer) was used for the purpose of this study. 
Immunolon B1 microtiter plates were coated with HCF, LL at 100µl per well, and left 
to incubate overnight at 4℃. The next day, plates were brought out and washed 
three times with washing buffer, 0.1%PBS Tween 20, as was at every stage of the 
assay.  Subsequently, plates were blocked with 0.3%PBS Tween 20 and 5% 
skimmed milk powder and left to incubate for 1hr at room temperature. All human 
sera samples were diluted to 1:100 in 0.3%PBS T20 and 5% skimmed milk powder 
and incubated for 1hr at room temperature, which was followed by incubation at 
1:10,000 (for HCF) dilution of anti-human IgG (whole molecule) conjugated to 
alkaline phosphates in 0.3%PBS T20 for a further incubation at room temperature for 
1hr, and 1:2000 for IgG subclasses 1-4. The substrate solution, consisted of 5mg p-
nitrophenylphosphate (PNPP) in diethanolamine buffer (pH 9.8) (3 tablets of PNPP 
in 15ml of diethanolamine buffer) was left to incubate at room temperature for 30min. 
The absorbance values, optical densities were measured at 405nm, using an 
automatic microplate reader (Thermo scientific multiskan FC). A dilution 
concentration of 1:100 was used for the LL antigenic material and sera, but a dilution 
concentration of 1:2000 was used for conjuagtes, whole IgG and IgG subclasses 
used for the purpose of this study. Absorbance values were read as above. 
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2.4 SDS-PAGE 
The separating gel, (12.5µl of Acrylamide stock, 11.2µl of TrisHCl pH8.8 and 6.2µl of 
distilled water, 300µl or 0.3µl of 10% SDS, 100µl of 10% freshly made APS and 20µl 
of TEMED (which causes polymerization), was loaded on the electrophoresis gel kit, 
gels were covered with butanol after loading to allow the formation of a fine, clean 
and smooth edge and left to polymerize for 1hr 45min. The stacking gel (1.75µl of 
Tris pH 6.8, 2.33µl of Acrylamide stock and 5.682µl of distilled water) was loaded 
and combs were inserted carefully immediately and left to polymerize for 1hr. 
Gels were transferred unto the electrophoresis kit, clamped tightly, connected to cold 
running tap and filled with running buffer, pH 8.3 to maintain the current. Combs 
were eased out carefully, and samples (equal amount of sample and sample 
cocktail, (in this case 50µl of each) that has been boiled for 5min) were loaded into 
wells. 20µl of the marker (MultiMark, Invitrogen) was loaded, as well as 20µl of each 
sample. To allow easy dissociation or separation of the proteins through the stacking 
gel, the gel was run at 100v at 20mA at the beginning, after which voltage was 
increased to 150v until the end of the electrophoresis. 
 
At the end of the assay, the gel was transferred into a tray, covered with coomasie 
blue for staining for 1hr, and covered with cling film and left on a rocking platform. At 
the end of 1hr, the gel was washed with distilled water, transferred into another tray 
and submerged in de-stain for 1hr, after which it was washed and re-submerged in 
fresh de-stain and left overnight on the rocking platform. De-stain was discarded the 
next day, the gel was washed in distilled water and images were taken under the UV 
light. 
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2.5 Western Blot/ Immunoblot. 
Extracts were fractionated by means of SDS-PAGE, after which gels were 
transferred carefully to an automatic blotting device (iBlot (Gel transfer device) by 
Invitrogen, and in 7min blotting was completed,  the nitrocellulose paper was washed 
and blocked with 0.3%PBS Tween 20 and milk for 1hr after which it was washed 
three times with washing buffer, 0.1%PBS Tween 20, followed by incubation with 
human sera samples with concentration of 1:100 and diluted in 0.3% PBS T20 with 
skimmed milk at room temperature. At the end of 1hr, this was followed by 
incubation with IgG subclasses, or IgG whole molecule at 1:5000 and 1:10,000 
respectively (for HCF), for 1hr at room temperature. Washing was done three times 
for 1min each at every stage of the assay. The substrate solution consisted of 1 
tablet of BCIP/NBT (Sigma) in 10mls distilled water and left to incubate at room 
temperature for 30min, after which photographs were taken under the UV light. 
 
 
2.6 Lectin Assay 
The lectin binding assay of the extracts of the laminated layer of E. granulosus was 
carried out according to Shimizu et al (1982) with little modifications as follows. The 
crude LL was electrophoresed as above on 12% polyacrylamide gel and transferred  
onto nitrocellulose papers (NCP). Proteins were transferred using iBlot (gel transfer  
device) by Invitrogen. After washing with PBS, the NCP was cut into strips and each  
strip was treated with 0.15M NaCl, 0.01M Tris-HCl, 0.5mM CaCl2 (pH 7.4) 
containing 1% bovine serum albumin (BSA) at RT for 1hour. The NCP strips were  
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washed with PBS afterwards for few minutes. Different peroxidase labelled lectins 
was dissolved in the above buffer at a concentration of 50µg/ml for 1hour. After 
incubation, the strips were washed again with the same buffer, but without BSA. The  
presence of lectin conjugates was visualised by the incubation of the NCP strips in  
10ml of 0.05% diaminobenzidine (DAB) and 0.01% H2O2 in 0.1M Tris- HCl (pH 7.4)  
at RT for 1-2min. The following peroxidase labelled lectins were used; Concanavalin  
A (Con A), Soybean agglutinin (SBA), Wheat germ agglutinin (WGA) and Horse 
gram agglutinin (DBA). (See table 3.1 for sugar specificities). 
 
 
2.7 Affinity Chromatography 
The work of Taherkhani et al (2007) indicated that the most significant 
immunoreactive bands in the laminated layer showed good binding with the WGA 
lectin. It was therefore decided to try to affinity purify these components from the 
crude extract, using WGA sepharose 4B column (Pharmacia, Germany). The choice  
of column was mainly because as described by Taherkhani et al (2007), WGA binds  
with the components on the LL and also because it was readily available at the time  
of this study. A 2 ml column was packed into a syringe according to the instruction of 
the manufacturer and equilibrated with 20 mMTris-HCl, pH 7.4 containing 0.5 M 
NaCl. The column was connected to a peristaltic pump and a UVI Cord optical 
density monitor also connected to a chard recorder. 0.5ml of laminated layer extract  
was run through the column and followed by 20 mMTris-HCl, pH 7.4, 
containing 0.5 M NaCl until the chart recorder reached base level. Adherent 
molecules were then eluted from the column using 0.2M α-D-methylglucoside. The 
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elution fraction was collected into eppendof tubes by observing the OD trace on the 
chart recorder and stored frozen until further use. 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3 
CHARACTERIZATION OF LAMINATED LAYER   EXTRACTS 
3.1 Introduction 
Larval echinococcosis (traditionally referred to as hydatid disease) is caused by the 
larval stages of the cestodes belonging to the genus Echinococcus in mammals, 
including humans (Thompson, R.C.A.1995). Basically; they have a bladder-like 
morphology and are established in the parenchymas of internal organs, especially 
liver and lungs. They are protected by a layer of extracellular, carbohydrate-rich 
material, termed the laminated layer (LL), which is syntheized by the underlying 
cellular germinal layer (GL). The LL is fundamentally a meshwork formed by higly O-
glycosylated glycoproteins of the mucin type. The glycans decorating these mucins 
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are hugely based on galactose and the structure is now partly known, even though 
the sequences of the corresponding peptide backbones are not (Diaz et. al, 2011). 
Evidently, the mucin meshwork accounts for the LL in E. multilocularis, and possibly 
the LL of a minor species, E. vogeli. In comparison, the LL of E.granulosus contains 
in addition, nanodeposits of calcium myo-inositol hexakisphosphate (Diaz et. al, 
2011). The LL is said to be the most important element of the host parasite 
interfaces in larval echinococcoses. Because it is the parasite structure that is 
exposed to the host, it is involved in multiple interactions with the immune system, 
and to a very large extent, it modifies the larval echinococcal infection immunology. 
 
―The LL is a macroscopically coherent and elastic structure, based on a microscopic 
three-dimensional meshwork of hydrophilic, highly hydrated fibrils‖. Viewed under the 
transmission electron microscope, the fibrils are arranged irregularly and are 
approximately 10mm in diameter (Diaz et. al, 2011).In addition to the fibrillar 
meshwork, E. granulosus is composed naturally of electron- dense granules that 
occurs individually or in clusters (Morseth, 1967). According to Richards et. al, 
(1983), these granules were not only determined to have 41nm size, but were also 
determined to be composed of from 8nm electron-lucent spheres fused together. 
These granules, even though conspicuous in E. granulosus, have never been 
reported in E. vogeli or E. multilocularis (Sakamoto and Sugimura, 1969, Ingold, et. 
al, 2001). 
The name laminated layer is got from the concentric laminations it shows under light 
microscope. Viewed under scanning electron microscope, the laminations give 
sectioned E. vogeli LL an open book appearance with pages that are very thin 
(Ingold et. al, 2001).  In contrast, the E. granulosus LL appears as more compact 
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(Elissondo et. al, 2007).The origin of the laminations is unknown (Morseth, 1967), 
but by viewing under transmission electron microscope, they appear to be a resultant 
from different compaction degrees adopted by a single type of ultrastructure. The 
fibrillar meshwork is comprised of the abundant carbohyrates that characterize the 
LL (Richards et. al, 1983). Pioneering works by Kilejian et. al, (1962); Kilejian and 
Schwabe, (1971), and Russi et. al, (1974) determined that the carbohydrate 
component could not be separated away from proteins. Kilejian et. al, (1962) defined 
the carbohydrate-protein complex as a mucopolysaccharide. It was a correct 
description at that time, even though, today, the term mucopolysaccharides refer to 
proteoglycans, which the LL does not contain.  
 
The LL meshwork is formed rather by the other major type of highly glycosylated  
glycoproteins, the mucins. According to kilejian et. al, 1962; Korc t al, 1967; Kilejian 
and Schwabe, 1971 ; Russi et. al, 1974 ;  the monosaccharide composition of the LL, 
galactose only (Gal), N-acetylgalactosamine (GalNAc) and N-actylglucosamine 
(GlcNAc) is only compatible with mucin-type O- glycans among the forms of 
glycosylation known in animals. In addition to the O-glycans, animal mucins can 
possess limited numbers of N-glycans (Devine and McKenzie, 1992). Nonetheless, 
in the LL constituents this does not seem the case, as mannose (invariably present 
in N-glycans) is not detectable in the crude hydatid cyst wall, i.e the GL plus the LL 
(Diaz et. al, 2009). In 2002, a purified molecule from E. multilocularis metacestode 
using anti- carbohydrate monoclonal antibody reacted selectively with the LL 
(Em2(G11), (Deplazes and Gottstein, 1991; Dai et. al, 2001), and based on its high 
molecular weight, high threonine content, and decoration with mucin type O-glycans 
was defined as a mucin (Hulsmeier et. al, 2002). The glycome of the E. granulosus 
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LL was recently tackled and mucin-type O-glycans that are related to those 
described in the E. multilocularis mucin were revealed (Hulsmeier et. al, 2002), but 
reaching larger sizes (Diaz et. al, 2009). 
 
According to Hokke et. al, (2007), the major features of the structure of the LL 
glycans are (1) the construction from cores 1 and 2 (2) the quantitative dominance of 
the non-decorated cores with respect to more elaborate glycans also present, (3) the 
lack of sialylation, expected in invertebrates; (4) the lack of fucosylation, which 
sharply contrasts with the glycobiology of schistosomes, (5) the elongation by 
(Galβ1-3)n , which was unknown previously; and (6) the capping of glycans by Galα 
1-4 (which are thought to be also probably present in protoscolex glycoconjugates 
(Baz et. al, 1999). The non-decorated core 1 is probably a major LL glycan across 
the genus, as the structural data suggests (Hulsmeier et. al, 2002; Diaz, et. al, 2009), 
and by the binding of lectins specific for it (PNA, Jacalin) to the LL of E. 
multilocularis, E. vogeli, and E. granulosus (Ingold, et. al, 2001; Ingold, et. al, 2000; 
Casaravilla and Diaz, 2010). Also, probably shared with other species is the virtual 
absence of N-glycans in the E. granulosus LL, as conconavalin A, which binds N-
glycans, labels the GL but not the LL of E. multilocularis (Ingold,  et. al, 2000), with a 
similar, although less clear-cut result obtained for E. vogeli (Ingold,  et. al, 2001). By 
contrast, some carbohydrates motifs present in the LL can be species specific. For 
example, neither the antibody Em2 (G11) nor a polyclonal antiserum against the E. 
multilocularis LL react with the E.vogeli LL (Deplazes and Gottstein, 1991; Ingold et. 
al, 2001). Also present in the E.multilocularis is the non-decorated O-linked GalNAc 
but not in the E. granulosus LL (Hulsmeier et. al, 2002 ; Diaz et. al, 2009). The 
deployment of a large huge LL especially in E. granulosus can be considered a 
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biosynthetic feat by the much thinner GL. Available microscopical evidence and 
biological common sense has made it clear that the GL carries out a polarized 
exocytic activity that results in LL build up (Rogan and Richards, 1989). More 
precisely, the GL syncytial tegument is responsible for this. There is similarity 
between this tegument and that present in the internal surface of the brood capsules 
and external surface of the protoscolices, it is syncytial and also microtriche bearing. 
Nonetheless, in comparison, the GL tegument is specialized, with that of the brood 
capsules being thicker and presenting numerous vesicles, and abundant, large 
mitochondria (Sakamoto and Sugimura, 1970), presumably, reflecting necessities 
associated with LL biosynthesis. The brood capsule functions to generate 
protoscoleces through inward budding. Nevertheless, brood capsules that are 
everted can synthesize an external LL, and probably give rise to daughter cysts 
(Rogan and Richards, 1986). Brood capsules that are intact can even synthesize an 
inward facing LL, in what is obviously an abnormal developmental pathway 
(Conchedda et. al, 2008). 
 
Therefore, the normally inward- facing tegumental pole of the brood capsule, similar 
to the outward-facing tegumental pole of the GL has a quiescent but normally 
suppressed capacity to secrete LL components. Notice should be taken that the 
protoscolex tegument can differentiate into GL tegument and the synthesize LL 
during reverse development towards metacestode, as it is obtained in secondary 
infections (Diaz et. al, 2011). Soon after the beginning of cystic development, the 
synthesis of LL starts. As early as three days after activation, E. granulosus 
oncospheres developing in vitro secrete fibrillate material. Although, its not until day  
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six that the fist material resembling the mature LL meshwork appears (Harris et. al, 
1989). A second wave of fibrillar material is secreted by day eight, which could be  
delineated outwardly and inwardly by particles possibly the InsP₆ deposits. The LL 
has been observed in vivo to appear 14 or 20 days after infection by E.multilocularis 
oncospheres (Rausch,1954; Sakamoto and Sugimura, 1970; Gottstein et. al, 1992). 
There is a probability, tendency that LL formation is delayed, appearing after 
approximately 28days in vitro (Heath and Osborn, 1976), or after 20-40 days in vivo 
(Rogan and Richards, 1989; Breijo,  et. al, 2008) when metacestodes develop from 
protoscolices, which need to become re-programmed for reverse development. With 
every chance and possibility, the LL O-glycans are synthesized in the Golgi 
apparatus of the GL tegumentary cells. Somehow, the LL must be turned over or re-
modeled. Subsequent and successive laminations are from the inside of pre-existing 
ones, pushing these towards the outside. The parasite can grow at the time of 
commencement of LL synthesis from approximately 30µm in diameter to tens of cm 
(for E. granulosus), the external strata of the LL must always be under tension 
(Harris et. al, 1989). This is manifested in the turgidity of normal E. granulosus cysts, 
and in solitary LL pieces curling up with the opposite concavity, hollowness to that 
found in the intact cyst (Richards et. al, 1983). 
 
In spite of the fact that the LL is elastic, elasticity on its own cannot explain growth by 
up to six orders of magnitude in linear dimension, and therefore mechanical and/ or 
chemical loosening of the structure must take place (Diaz et. al, 2011). The need to 
(1) provide mechanical support for the turgidity of metacestode, possibly a 
contributory factor to parasite growth, and (2) protect GL cells from host immunity, 
might have influenced the main evolutionary pressures that gave rise to the LL. 
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Fulfilling the functions must be done in such a way that parasite nutrients and waste 
products are allowed passage, and parasite growth is permitted. The physically 
coherent, elastic, hydrophilic meshwork, that allows the diffusion of macromolecules 
to at least up to 150KDa has been the evolutionary answer to these requirements 
(Coltorti and Varela-Diaz, 1974), but protects the GL from host leukocytes. The 
parasite is not utterly made insensitive to host inflammation, this is attested for by the 
death of established metacestodes when inflammatory resolution fails. It instead 
bestows a partial protection against host effectors, but furthermore and more 
importantly, it appears to downregulate inflammation. The major source of 
Echinococcus molecules that the immune system of the infected host comes in 
contact with must be the massive LL. ―This comprised the adhesion of leukocytes to 
LL external surface and the interaction, the relationship that is between soluble host  
recognition molecules and the large solvent exposed area represented by the entire 
thickness of the LL‖ (Diaz et. al, 2011), additionally, material shedding from the LL 
outer strata is a prerequisite for parasite growth. Recognised molecules by LL 
monoclonal reactive antibodies are released from E. multilocularis vesicles in vitro 
(Gottstein et. al, 1992; Walker et. al, 2004). Host macrophages, in experimental 
infections adhere to the LL outer surface and bring about the phagocytosis of LL- 
derived particles (Richards et al, 1983; Gottstein and Hemphill, 1997). Together, the 
large exposure of the host immune system to the LL and the complete profile of 
regulatory responses in larval echinococcoses suggest that the components of LL 
bring about regulation.  
 
This view, widely held (Rogan, 1998; Conchedda et. al, 2004; Vuitton and Gottstein, 
2010), is supported by observations that inflammatory resolution in E. granulosus 
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and E. vogeli infections correspond in time with LL deployment (Rausch, 1954; Breijo 
et. al, 2008), which, depending on the model, takes place two to six weeks post-
infection (Diaz et. al, 2011). Currently, the immunological reasoning behind whether 
the LL induces regulation dictates that for it to be then the innate immune system 
must have interpreted it as a non- dangerous material, consequently initiating 
pathways that generate adaptive regulatory responses (Diaz, and Allen, 2007). 
Evasion of the immune system by chronic pathogens is now indeed believed to be 
dependent on expansion and/ or the recruitment of natural and/ or adaptive Treg 
cells locally (Grainger et. al, 2010), in addition to the induction of IL-10 expression by 
effector T-cells (Jankovic, et. al, 2010). 
 
 
3.2 MATERIAL AND METHOD 
The laminated layer was prepared as described by Taherkhani et. al, (2007). The 
laminated layer was carefully removed from the whole cyst under magnifying 
microscope using forceps and blades. After which the parasite layer was kept frozen, 
and then thawed and cut into 1cm strips, put in 1ml PBS and freeze-thawed twice. 
Upon thawing, the laminated layer was weighed, and for the purpose of this study 
17g was used. The strips were cut into smaller pieces and ground to a pulp using 
mortar and pestle. The mixture, i.e.17g of laminated layer and 17mls of 10% PBS 
was transferred into a plastic beaker, put on ice, and sonicated in a 150W sonicator 
for 2minutes at 10secs on and 10secs off cycle. The resultant milky-like liquid was 
transferred to sterile 1.5ml eppendof tubes and centrifuged at 10,000 rpm for 
15mins. The supernatant was transferred to new sterile tubes and stored at -20℃ 
until use. 
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3.3 RESULTS 
Extracts of the laminated layer of E. granulosus were fractionated by SDS-PAGE 
under reducing conditions. Results obtained showed bands in the 8, 22, 55 and 
98KDa regions. 
 
3.3.1 SDS-PAGE 
                         
 
 
 
 
  
 
Figure 3.1: An SDS-PAGE Image showing the dissociation of the LL proteins as  
compared to HCF. Lane 1 (Marker), Lane 2 (HCF), Lane 3 (LL). 
 
 
3.3.2 Reactivity of the Laminated layer in ELISA 
To test whether the laminated layer extract was recognised as an antigen in ELISA, 
fourteen hydatid positive samples were tested for Total IgG and IgG1 and IgG4 
subclass responses. These were compared with Sheep Hydatid Fluid antigen. 
 
98kDa 
55kDa 
22kDa 
8k  Da 
 M     HCF      LL 
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Figure 3. 2: Initial ELISA for fourteen confirmed Hydatid patients screened against cyst fluid 
(HCF) and Laminated layer (LL) antigens. The horizontal line represents the background 
level for clinically negative sera for both antigens. 
 
3.3.3 Immunoblots 
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Figure 3.3: Immunoblot images of the reactivity of (A) Total IgG with HCF (Figure 3.3A), (B) 
Total IgG with extracts of LL (Figure 3.3B), both tested with pooled positive sera. Both 
samples recognise bands at 22 and 36KDa. Bands at 55KDa were also recognised by the 
LL. 
                                                                
                     
                                               
 
                                                      
 
 
 
Figure 3.4: Blot images for the negative controls for the reactivity of (A) Total IgG with  HCF 
(Figure 3.4A), (B) Total IgG with LL (Figure 3.4B). Both were tested with negative sera. 
There are no bands present on the LL but a band at 98KDa was recognised by HCF. 
        
                                                                                                                                 
     
 
 
 
 
 
                                                                                                   
Figure 3.5: Blot Images for the reactivity of  IgG1 with HCF with pooled positive sera. The 
band recognised is the one at 55KDa by HCF. No visible bands with the LL and so images 
were not included. 
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Figure 3.6 Blot images showing positive results of the reactivity of (A) HCF with IgG4 
(Figure 3.7A) and (B) LL with IgG4 (Figure 3.7B). Both were tested with pooled positive sera. 
Again, as with positive IgG1, there were no bands recognised with the LL, while HCF, 
though not strongly have bands recognition at the 55, 98 and 148KDa regions.  Images for 
the negative controls were not included as there were no apparent bands observed. 
 
           
 
3.4 LECTIN BINDING ANALYSIS 
Analysis of the laminated layer was carried out using series of lectins to investigate 
and characterise the carbohydrate components, since, according to Walker, (1994), 
laminated layer contains a considerable amount of carbohydrate components. 
Lectins are protein molecules that bind carbohydrates and each lectin have different 
sugar specificities (Walker, 1994). 
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Table 3.1 Table showing the different carbohydrates used in the analysis of 
lectin binding and their carbohydrate specificities (Major and Minor).  
 
Lectin Major Minor 
 
Concanavalin A (Con A) 
(Canavalia ensiformis) 
Α-Methyl-D-Mannoside Α-D-Glucose, N-Acetyl- 
α-D-Glucosamine 
 
Soybean agglutinin (SBA) 
(Glycine max) 
 
N-Acetyl-α-D-
Galactosamine 
N-Acetyl-β-D-
Galactosamine 
 
None 
 
 
 
Wheat germ agglutinin 
(WGA) 
(Triticum vulgaris) 
 
N-Acetyl-β-D-Glucosamine 
 
None 
 
 
 
Horse gram agglutinin      N-Acteyl-α-D-Galactosamine  α-D-Galactose 
(DBA) 
(Dolichos biflorus) 
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Figure 3.7 Glycoprotein patterns of the laminated layer antigen as detected by lectin. Major 
bands have been detected by SBA,WGA and ConA at the 31KDa region.   
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3.5 DISCUSSION 
There have been no detailed studies on the analysis of the laminated layer of E. 
granulosus with SDS-PAGE, ELISA and Immunoblotting. The laminated layer 
contains various host and parasite molecules (Walker, 1994), it is therefore important 
to characterize  each component.  
 
In this cuurent study, extracts of crude laminated layer were analyzed using SDS-
PAGE (under reducing conditions), ELISA, Immunoblotting and lectin asssay. An 
SDS-PAGE analysis stained in coomasie blue was done under reducing conditions 
to compare the extracts of laminated layer with HCF. Results show both antigenic 
materials with similar profiles, detecting bands at the 8, 22 and 55KDa (Figure 3.1). 
This assay was directly followed by an intial ELISA to confirm results obtained from 
the SDS analysis (see Figure 3.2). All fourteen confirmed patient samples gave 
positive response to HCF and the LL, with the LL having an overall greater response 
with all samples tested.  
 
Analysis of the HCF and the LL by immunoblotting was carried out to further analyse 
the laminated layer and identify specific bands that can be used in the purpose of 
post-treatment follow-up. Reactivity of HCF and the LL with total IgG gave a common 
band recognition in the regions of 22, 36 and 55KDa (see Figure 3.3) and differently, 
HCF went on to detect bands at 64 and 98KDa (Figure 3.3). There were no bands 
detected with the LL for the negative controls, but a band at 98KDa was detected for 
HCF (Figure 3.4). 
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With IgG1, bands were only detected at the 55KDa region, there were no bands 
detected by the LL, therefore images were not included (Figure 3.5). The results 
obtained for negative controls show no apparent bands were detected by both HCF 
and the LL, therefore, images were not included . Bands at the 55, 98 and 148KDa 
regions were detected by HCF with IgG4, no bands were detected by the LL (Figure 
3.6). Results and images for negative controls have not been included as there were 
no apparent bands showing. 
 
In order to analyse and visualise the carbohydrate component of glycoprotein bands 
in the laminated layer, the crude LL was probed with various peroxidase labelled 
lectin conjugates (Table 3.1). Results (Figure 3.9) showed that the ConA, SBA and 
WGA all recognise major bands at the 31KDa region. Bands were also recognised 
by WGA and ConA at the 50KDa region. No bands were recognised by DBA. 
 
The ability of these lectins;  ConA, WGA, and SBA to have recognised bands on the 
surface of the extracts of the crude laminated layer of E. granulosus suggests the 
presence of α-Methyl-D-Mannoside, N-Acetyl-β-D-Glucosamine and N-Acetyl-β-D-
Galactosamine in the laminated layer.  The bands at the 31KDa region stained 
heavily for the presence of  ConA, WGA and SBA.  
 
Of particular interests are the results obtained with the reactivity of  the laminated 
layer of E. granulosus with IgG1 and IgG4 as there were no bands detected when 
tested with these antibody isotypes (Figures 3.5 and 3.6 respectively). This is in 
agreement with the findings of Daeki et al, (2000) who stated that low concentration 
or reactivity of IgG1 and IgG4 is associated with disease regression or possible 
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calcification and again indicates that IgG4 is a good tool marker that can be used in 
the post-treatment surveillance of hydatid disease. The recognised bands by HCF 
and the laminated layer at 98 and 148KDa (Figures 3.3A, 3.4A, 3.6A, respectively) 
are probably host globulins and not parasitic in origin. According to Papadea and 
Check, (1989) the monomeric IgG had molecular weight of approximately 150KDa 
which dissociated into two groups of 22KDa light chains polypeptides and five types 
of heavy chains with molecular weights around 50-70KDa. This study is therefore in 
agreement as bands have been detected by HCF and the laminated layer at 148KDa 
region. 
 
Bands recognised by HCF and the LL for positive assays at 22, 36 , 55KDa confirms 
the presence of antigen B (AgB) and antigen 5 (Ag5) in the HCF and LL antigenic 
materials. Carbohydrate antigens with molecular weights higher than 45KDa were 
reported by Miguez et al, (1996) in E. granulosus protoscolex using antisera raised 
from a carbohydrate enriched soluble fraction. There is a similarity between this 
result and the current study where the presence of carbohydrates were detected on 
bands in the 50-55KDa (N-Acetyl-β-D-glucosamine and/ or α—Methyl-D-
Mannoside), and in the 60-66KDa (N-Acetyl-β-D-Galactosamine and/ or β-D-
Galactose-(1-3)-N-Acetyl-Galactosmine linkage). 
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CHAPTER 4  
 LECTIN AFFINITY PURIFICATION 
 
4.1  INTRODUCTION 
Cystic hydatid disease is caused by E. granulosus in humans and transmission of 
the parasites naturally occurs between carnivorous as definitive hosts and 
herbivorous as intermediate hosts. Human infections occur accidentally via hand to 
mouth when comimg into contact with infected faecal matter contaminated with eggs 
e.g when petting dogs (CITE). 
 
The cyst wall of metacestodes consists of inner, middle and external layers. The 
middle layer, otherwise known as the laminated layer is unique to the genus 
Echinococcus in comparison with other larval cestodes. Young cysts do not possess 
this layer and it is not until about 14-18days old when the first appearance is noticed 
as a thin, clear layer on its outer margin. This layer is an acellular, polysaccharide 
protein complex that stains strongly by periodic acid, Schiff‘s reagent (PAS) and 
equally provides a useful diagnostic marker in histological studies (Kilejian et al., 
1962; Craig et al., 1995).  
The laminated layer is given rise to by the inner germinal  layer (Ortoletti and 
Ferretti., 1978; Harris et al., 1989; Holcman et al., 1994). Host material may be 
contributory to its structure (Kilejian and Schwabe , 1971; Pezzella et al., 1984). It 
has been shown the laminated layer (LL) of E. granulosus contains more of 
galactosamine than glucosamine. However, in protscolices (Px) and hydatid cyst 
fluid (HCF)  glucosamine is more abundant than galactosamine. Also exhibited in the 
laminated layer is acid muco-polysaccharide (Richards, 1984). 
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 In terms of antigenicity, Gottstein et al, (1983) isolated a lectin-binding carbohydrate 
antigen (Em2) of a specific fraction from crude metacestode of the E. multilocularis 
by immunoaffinity chromatography against anti E. granulosus hydatid fluid IgG 
coupled to CNBr-sepharose 4B. The molecular mass of this antigen is 54KDa 
(Gottstein, 1985; Furuya et al., 1989; Gottstein, 1992; Gottstein and Felleisen, 1995). 
In their study of carbohydates on the surface of E. granulosus protoscolices (Px) in 
mice, Migues et al, (1996) showed that carbohydrates were largely bound to parasite 
surfaces and were highly immunogenic. In spite of the fact that the laminated layer of 
E. granulosus is largely made up of carbohydrate components, little attention has 
been received by the role of these components in immunogenicity. 
 
Taherkhani and Rogan, (2000), reported following SDS-PAGE and Westernblot 
analysis, that the most important antigenic molecules of the laminated layer of E. 
granulosus are those confined to these two regions (50-66KDa and 25-29KDa).  
Since lectins are carbohydrate binding protein that interacts with specific sugar 
moieties, a further characterisation of  the carbohydrate components in these regions 
using a series of lectins to detect whether these molecues are glycoprotein was 
carried out by Taherkhani and Rogan, (2000). 
 
Over the years, attempts to isolate glycoproteins from organic specimens have been 
made resulting in the development of a wide range of chemical and biological assays 
currently used for separating target proteins from crude mixtures (CITE), one of 
which is the lectin affinity chromatography assay (CITE).  
Lectins or agglutinins as they are also known , are able to recognise and bind 
reversibly to specific sugar moieties of polysaccharides, glycoproteins and 
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glycolipids found in biological systems in the form of either serum proteins or as 
membrane-associated proteins (Hart, 1980).  They have previously been used for 
separating glycosylated proteins from non-glycosylated proteins (Sharon, 1993; Ling  
et al, 2012).  Proteins were first separated using a Concanavalin-A lectin/Sepharose 
4B assay using cyanogen bromide (CNBr) as a means of immobilization  for coupling 
proteins to the matrix, a method developed by Axen et.al (1967), however, due to the 
toxic gases that can be produced fom CNBr, an alternative modified assay using 
affinity chromatography on Con A-Sepharose using DEAE (Diethylethanolamine) as 
the immobilizer has been successfully used to purify alkaline phosphatase from 
human liver (Trepanier et al, 1976) 
The work of Taherkhani et al (2007) indicated that the most significant 
immunoreactive bands in the laminated layer showed good binding with the WGA 
lectin. It was therefore decided to try to affinity purify these components from the 
crude extract, using WGA Sepharose 4B column ( Pharmacia, Germany). 
 
 
4.2 AIM 
The aim of this particular assay was purify the extracts of the laminated layer of E. 
granulosus with the propsect of the using the purified extracts as antigenic material 
for further serological investigations with the hope of finding a serological parameter 
that can be useful in the diagnosis and follow-up of cystic hydatid disease. 
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4.3  RESULTS 
A 2ml column was packed into a syringe according to the manufacturers instructions 
and equilibrated with 20mM Tris-Hcl (pH 7.4) containing 0.5M NaCl. The column was 
connected to a peristaltic pump and a UVI cord optical density monitor and also 
connected to a chart recorder. Extracts of laminated layer (0.5ml) was run through 
the column and followed by 20mM Tris-HCl (pH 7.4) containing 0.5M NaCl until the 
chart recorder reached base level. Adherent molecules were then eluted from the 
column using 0.2M α-D-methylglucoside. The elution fraction was collected in 
eppendof tubes by observing the OD trace on the chart recorder and stored frozen 
until further use. 
 
The obtained purified extracts were subjected to further analysis using pooled 
hydatid sera and normal sera in ELISA. Results show greater reactivity of total IgG 
towards antigens (Figure 4.2a). The runs tested with IgG, IgG1 and IgG4 ( Figure 4.2 
A, B, and C) have given higher results and reactivity than the obtained eluates. 
The eluates, which represent the bound / adherent proteins have not given good 
results when tested with total IgG and IgG subclasses 1 and 4. 
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Figure 4.1 
The chart recorder showing run through and elution peaks. Crude extract of laminated layer 
was run through the column and was recorded by the chart recorder before been eluted 
using 0.2M α-D-methylglucoside. Peak on  
column indicate elution points. 
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Fig 4.2: Graphs showing ELISA results of obtained eluates of the LL in reactivity with IgG, 
IgG1 and IgG4. They are shown to have low reactivity against total IgG Figure 4.2A), IgG1 
(Figure 4.2B) and IgG4 (Figure 4.2C). In all three graphs, especially with total IgG (Figure 
4.2A), the runs are seen to have a higher response. 
 
A 
B 
C 
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4.3   DISCUSSION 
Affinity chromatograpghy was first recognised as a seperation technique by Axen et 
al (1967). It is a technique that can be used for the purification of substances from 
complex biological mixtures and for the removal of small amounts of biological 
material from large amounts of contaminating substances. Therefore, in order to 
purify polyclonal antibody or antigen complex, the affinity columns were employed 
which are consisted of antibody or antigen fixed onto sepharose beads. One of the 
advantages of the affinity chromatography technique is its ability to isolate a solute 
from a biological material selectively. Nevertheless, the slow adsorption-desorption 
kinetics of many proteins usually causes contamination of the eluted protein, 
suggesting a draw back in the use of the technique for the preparative work as well 
as for the quantitative analysis purposes. 
 
The use of affinity chromatography as a technique, a molecular investigative tool has 
been employed by so many  and in so many laboratories around the globe. 
Fornstedt (1984) employed the technique when he did studies on the dissociation of 
Antigen-Antibody. 
The technique was also used as a tool by Schiel and Hage (2009) in their study to 
examine the kinetics of biologicall interactions. In their approach, referred to as 
biointeraction chromatography, they used a column with an immobilized binding 
agent to examine association or dissociation of this agent with other compound. 
Stewart and Doherty, (1973) also adopted the affinity chromatography technique 
when they selected bovine-serum albumin, known to have antipodal specificity in the 
binding of tryptophan as the affinity chromatographic matrix for the attempted 
chromatographic resolution of DL- tryptophan. They accomplished a complete 
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resolution when DL-tryptophan was chromatographed on bovine-serum albumin 
succinoylaminoethyl-sepharose. 
The use of the affinity chromatography can not be over emphasized.  
The aim and objective of this study and the purpose for employing the use of this 
assay was to separate host serum components from the crude laminated layer so as 
to obtain a purified laminated layer that can be used as an antigenic material with a 
view to obtaining distinct and reliable results upon testing with sera from our panel of 
confirmed hydatid disease patients. 
After the crude extracts of laminated layer was run through the affinity 
chromatography column, eluates obtained were further subjected to ELISA in order 
to ascertain their level of antigenicity. Results showed poor reactivity of IgG1 and 
IgG4 subclass antibodies towards the LL antigen (Figure 4.2B and C), however, 
serum IgG antibody showed a much higher response towards the same antigen 
(Figure 4. 2 A). This could be because the laminated layer extracts used was not 
contained of viable antigenic materials or binding was  poor or  because nothing 
bound to the WGA Sepharose column used as WGA is known to be specific for N-
Acetyl-β-D-Glucosamine, and maybe this carbohydrate was not present on the 
surface of the laminated layer used and therefore not present on its extracts or not 
present in enough quantity as to be able to cause a reaction.  Another reason for the 
poor results obtained in general from this assay could be because there were not 
enough antigenic proteins released from the laminated layer. The same laminated 
layer source was used all through this present study and encouraging results were 
obtained using the same laminated in SDS-PAGE, ELISA and Immunoblots. This 
could be because, the adherence in the ELISA plates are higher and therefore boost 
the ability of our antigenic material (LL) to adhere and cause a reaction. Regarding 
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SDS-PAGE, it could be as a result of the boiling before use and the addition of 
sample cocktails used to break down into reducing conditions that helped in the 
dissociation of the LL giving rise to release of proteins and ultimately the bands 
obtained. All of these of course would need to be substantiated by further studies. 
It is rather unfortunate that no encouraging results were obtained from affinity  
chromatography assay, but it can not be over emphasized that it is an assay that has  
proved its worth and usefulness over time and this is again depicted by the study of  
Abdi et al (2010). Abdi et al, (2010) cloned a 12KDa subunit of antigen B from E.  
granulosus, expressed and used it in diagnostic ELISA to test human sera for  
evidence of cystic echinococcosis. They compared the performance of the ELISA  
based on the recombinant antigen (rAgB) with that of similar assays based on native  
antigen B (nAgB) or hydatid cyst fluid. They further purified the recombinant protein  
using affinity chromatography. According to their results, the performance of the  
ELISA based on cyst fluid appeared identical to that of the assay based on the  
recombinant antigen. 
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CHAPTER 5  
USE OF LAMINATED LAYER IN FOLLOW UP AFTER TREATMENT 
5.1 INTRODUCTION 
Continuous, repeated assessments of hydatid cyst viability are commonly made 
using serial radiology with or without serial serology. Nevertheless, there is no test 
for cure and therefore follow-up surveillance is required for many years. Lawn et al, 
(2004) reported that an enzyme linked immunosobent assay (ELISA) measuring CE-
specific total IgG is the main serologic test used for diagnosis and follow-up at the 
Hospital for Tropical Diseases (HTD) in London. However, they stated that their 
experience with the test is that although a gradual decrease in optical density (OD) 
overtime following treatment maybe recorded, rarely does the test result become 
negative even after many years, even in those in whom it is apparent that the 
disease is cured. Likewise, serial radiology is often unreliable in demonstrating or 
establishing parasitologic cure; cysts killed by chemotherapy may persist and post-
operative defects cannot always be distinguished/ separated from viable cysts. 
 
Studies have reported previously that IgG subclasses 1-4 are expressed in different 
degrees in patients with chronic helminthic infections (Boctor and Peter, 1990, Short 
et al, 1990, Kurniawan et al, 1993). Likewise, the use of an ELISA incorporating 
partially purified hydatid cyst fluid antigen B to do cross-sectional studies of patients 
with CE have found a predominance of IgG1 and IgG4 expression in serum (Aceti et 
al, 1993; Wen and Craig, 1994; Shambesh et al, 1997; Daeki et al, 2000). 
Furthermore, compared with those with asymptomatic disease, serum 
concentrations of IgG4 are greater in patients with symptomatic CE (Shambesh et al, 
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1997). Therefore, suggestions have been made that measurements of IgG sbclass 
may provide a more sensitive index of disease activity than CE-specific total IgG. 
Owing to the frequent lack of sensitivity of immunodiagnosis, diagnosis of CE 
remains highly dependent on imaging techniques (Zhang and McManus, 2006) with 
about 20% of clinically or surgically confirmed CE cases, and negative serology 
being presented by up to 50% of community-detected patients (Verastegui et al, 
1992; Moro and Garcia, 2005). The most commonly used imaging techniques 
include magnetic resonance imaging (MRI), Ultrasonography (US) or radiography, 
for detection of characteristic space-occupying cysts (McManus et al, 2003; Eckert 
and Deplazes, 2004). MRI shows highly specific features of CE, but it is prohibitively 
expensive and not readily available in rural areas of many endemic countries. 
Ultrasound is contrastingly more accessible, much less expensive, and can identify 
hydatid cyst pathological type CE1 to CE5 (Brunetti and Junghanss, 2007). 
 
According to Brunetti and Junghanss (2007), surgery, percutaneous techniques, 
antiparasitic treatment for active cysts, and the so- called ―watch and wait‖ approach 
for the inactive cysts are some of the approaches employed in the clinical 
management of CE. Surgery currently remains the commonest approach for CE 
treatment that possess the potential to remove cyst and lead to absolute cure, but 
risks are involved, including those associated with any surgical intervention, 
anaphylactic reactions, and secondary CE due to spillage of viable parasite 
(protoscolices) material (WHO, 1996; Junghanss et al, 2008; Brunetti et al, 2010). 
The use of drug therapy, especially with benzimidazoles (albendazole or 
mebendazole) has been on the increase with CE treatment, and efficacy against the 
parasite in humans have been proven, with about 30% of patients cured and 30-50% 
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of cases improved after 12months folloow-up (WHO, 1996). However, the response 
to drug therapy can be unpredictable, and the optimum not been determined 
definitively (Junghanss et al, 2008; Stojkovic et al, 2009). Furthermore, recurrence 
risk remains the major problem in surgical or medical treatment (WHO, 1996;  
Stojkovic et al, 2009; Brunetti et al, 2010). Therefore, post- treatment or post-surgical 
follow-up of CE patients for several years is usually suggested. 
 
Table 5.1 SUMMARY OF PATIENTS INFORMATION 
Patient 
ID 
Gender/ 
Age 
Cyst 
series 
Organ Involvement ALB 
Chemotherapy 
(mg/kg body 
weight)/ 
surgery 
Sera 
Timeline 
B142 Female 
6 
CE1, 
CE4 
R/ liver Untreated 0-
42.7months 
P160 Female 
16 
CE2, 
CE3 
R/ liver Untreated 0-
33.9months 
X345 Female 
20 
CE2, 
CE3 
Omentum/ 
mesentery 
Untreated 0-3.6months 
X161 Female 
17 
CE3, 
CE4 
R/ liver 27.6mths ALB 
(20mg). 
0-
31.6months 
Y88 Female 
5 
CE1 R/ liver 4.8mths 2 
courses ALB 
(20mg); 
17.8mths ALB 
(20mg). 
0-8.4months 
Y13 Female 
20 
CE1, 
CE3, 
CE4, 
CE5 
R/ liver, lower 
abdomen 
3.8mths 3 
courses ALB 
(20mg); 
22.2mths ALB 
(20mg); 
58.7mths ALB 
(20mg); 
62.3mths 
endocystectomy
. 
0-
209.8month
s 
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Y28 Female 
20 
CE1, 
CE3 
R/ liver 5.5mths 3 
courses ALB 
(20mg); 
41.6mths 
cystectomy and 
2 courses ALB 
(20mg). 
0-
46.9months 
Y51 Female 
10 
CE1, 
CE3, 
CE4 
R and L/liver, 
Omentum/mesenter
y 
1.6mths 1 
course ALB 
(20mg). 
0-
10.5months 
X269 Female  Data  
not 
availab
le 
Kidney Untreated Data not 
available 
Y63 Female 
25 
CE1, 
CE3 
R/ liver At point ―0‖ 1 
course ALB 
(20mg). 
0-
47.3months 
Y179 Female 
22 
CE2, 
CE£ 
R/ liver 0.1mths 3 
courses ALB 
(20mg); 
15.1mths ALB 
(20mg); 
23.9mths ALB 
(20mg). 
0-
42.7months 
Y235 Female 
46 
CE2, 
CE3 
R/ liver 2.2mths ALB 
(20mg). 
0-6.2months 
Y111 Female 
30 
CE1, 
CE2, 
CE4 
R and L/ liver 0.1mths 3 
courses ALB 
(20mg); 
15.1mths ALB 
(20mg); 
23.9mths ALB 
(20mg). 
0-
46.2months 
156 Female 
33 
CE2 R and L/ liver, 
Omentum/ 
mesentery 
1.8mths 2 
courses ALB 
(20mg); 4.2mths 
had 
endocystectomy
. 
0-4.1months 
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5.2  RESULTS 
Extracts of laminated layer was tested and compared to HCF in an ELISA assay in 
order to determine the levels of sensitivity between the two when tested against total 
IgG and IgG1/IgG4 subclass antibodies. 
All samples, untreated (table 5. 2, n =4) and treated (table 5. 3, n =10) were tested 
with ELISA to determine levels of total IgG, IgG1 and IgG4 subclasses in response 
to HCF and LL antigens. There are two tables below, table 5.2 is a summary of the 
antibody responses obtained for both laminated layer and HCF for untreated 
patients, while table 5.3 shows summary of antibody response for treated patients.  
In determining whether the antibody responses obtained are low, medium or high, 
the OD values were taken into consideration and was decided that any response 
between OD value 0 and 1 is considered low and between 1 and up to 2 is medium, 
while anything higher than 2 is high (as evident on graphs). 
 
 
Table 5.2     ANTIBODY RESPONSE (UNTREATED PATIENTS) 
SAMPLE ID IgG-HCF IgG-LL IgG1-HCF IgG1-LL IgG4-HCF IgG4-LL 
B142 low low low low low low 
P160 low high med med low low 
X269 low low low low low low 
X345 med med high low low low 
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B142: Patient B142 is a low responder, and in all cases little reactivity was seen of 
serum IgG, IgG1 and IgG4 towards all antigens (Table 5.2, Figure 5.1) 
P160: With Patient P160, a different trend was seen. Even though the same line 
trend was obtained for both LL and HCF in reaction with IgG, LL gave a higher  
response (Table 5.2, Figure 5.2A). A similar result  to that obtained for total IgG was 
obtained for IgG1. Again, LL was shown to have a higher response (Table 5.2, Fig 
5.2B). Interestingly, response of both antigenic samples, LL and HCF to IgG4 was on 
the same level and both have shown similarity in trends (Table 5.2, Figure 5.2C). 
X269: Patient X269, like B142 is a low responder and has shown very low reactivity 
with neither of total IgG or immunogloblulin subclasses 1 and 4 (Table 5.2, Figure 
5.3). 
X345: Patient X345 in reactivity with total IgG. Both antigenic samples are low 
responders; both have displayed similar reactivity/ response  and significant peaks at 
0 and 1.55months respectively (Table 5.2, Figure 5.4A). Antibody response with 
IgG1 are noticeably very different. The LL is obviously a low responder while HCF 
responses are higher, peaking twice at 0 and 1.55months respectively and then 
experiencing sharp falls after reaching these peaks (Table 5.2, Figure 5.4B) .Again, 
with IgG4, both antigenic samples are low responders, antibody response patterns 
here are similar. Reactivity recorded for both samples was very low (Table 5.2, Fig 
5.4c). 
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Table 5. 3          ANTIBODY RESPONSE(TREATED PATIENTS/ SAMPLES) 
SAMPLE 
ID 
IgG-HCF IgG-LL IgG1-HCF IgG1-LL IgG4-HCF IgG4-LL 
X161 low high low med low low 
Y13 low low low High/low low low 
Y28 low low low low low low 
Y51 low high low high med low 
Y63 med low Low/high low low low 
Y88 low high low High/med low High/low 
Y111 low High/low low low low low 
Y179 low med low low low Low/high 
Y235 low low low low high low 
156 med med med low med low 
 
 
Patient X161. Figure 5.5A is the result obtained for reactivity with total IgG where it is 
shown that there is not so much activity going on with HCF. It is noticeably a low 
responder (Table 5.3); the LL is displaying a much higher response, although there 
are no major peaks observed. Similarly, with IgG1, HCF again gives a lower 
response when compared to LL with a medium response. No major peaks observed 
here and the antigenic samples have shown variations in their line trend (Figure 
5.5B). A slightly different result was obtained for reactivity with IgG4. Both LL and 
HCF show same line trend and are both low responders with HCF seen to be picking 
up (Figure 5.5C). With Patient X161, the LL seems to have greater serum response 
and activity with total IgG displaying the highest level of antibody activity. 
Y13: Patient Y13 is an interesting one, as observed in Figure 5.6A, antibody 
response and reactivity is similar for both LL and HCF and both are low responders. 
An almost but slightly different result is recorded for the same samples in reactivity 
with IgG1 (Table 5.3, Figure 5.6B) where HCF remains a low responder but LL starts 
as a high responder then becoming a low responder with almost no reactivity going 
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on. Same line trend observed from 20.24months. A completely different result was 
obtained for the reactivity of these samples with IgG4. From the graph (Figure 5.6C), 
it was obvious that both are low responders. 
Y28: Patient Y28. With this patient, both samples gave very low responses in 
reactivity to total IgG and the subclass isotypes IgG1 and IgG4. The reactivity with 
total IgG, IgG1 and IgG4 have displayed responses that are similar except for the  
little variation displayed with reactivity with IgG4 (Figure 5.7C). 
Y51: Observable with patient Y51 is the higher response to total IgG in serum 
antibody level given by LL than towards HCF (Table 5.3, Figure 5.8A). No major 
peaks are observed. A different result was obtained for reactivity with IgG1 (Table 
5.3, Figure 5.8B). Although they have both responded similarlys, both started off as 
low responders before they both rise at 2.27months (LL rising significantly higher) 
and peaking at 2.56months and then experiencing a fall. A variation in response to 
antibody was observed for reactivity with subclass IgG4 (Figure 5.8C). HCF peaked 
significantly at 5.49months (Figure 5.8C).  
Y63: Patient Y6; here both antigenic samples gave low response to total IgG, 
although response to antibodies was similar. A slightly raised activity was observed 
between 0.49-34.68months (Table 5.3, Figure 5.9A). In response to subclass IgG1, 
both antigenic samples started off as low responders before HCF experienced a rise 
in activity at just after 0.49months and then peaking at 2.82months before 
experiencing a sharp fall (Table 5.3, Figure 5.9B). Result obtained for reactivity with 
subclass IgG4 are similar to that obtained for subclass IgG1. Both antigenic samples 
are considered low responders, but again between 0.95 and 34.68months, HCF 
experienced a rise in activity so also LL with a noticeable slight raise in activity 
(Table5. 3, Figure 5.9C). 
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Y88: Patient Y88 showed some interesting trends as serum antibody levels in 
response to the LL antigen had greater activity than towards HCF antigen (Table 5. 
3). Total IgG antibody displayed the highest level of antibody activity, noticeably 
peaking at 2.6months followed by a decrease in reactivity after treatment with ALB 
(20mg/kg) just over 2months later. Antibody level then rises slightly higher at 
5.7months then begins to drop continuing to drop significantly after treatment 
(20mg/kg) at 7.2months (Figure 5.10A). A sharp rise is then seen with IgG activity 
peaking at about 8.4months. In contrast, total IgG response towards HCF antigen 
shows a flat line response throughout. With IgG1 antibody, responses to the LL 
antigen (Figure 5.10B) show a very similar trend, with peaks corresponding to those 
shown by total IgG but at a lower level of reactivity. Similarly, a flat line response is 
also noticed with IgG1 towards HCF antigen. A similar set of results is demonstrated 
for reactivity of IgG subclass 4 antibody (Figure 5.10C) in response to both antigens 
and again, a flat line response is seen towards HCF antigen. However, with this 
subclass- antibody, only one significant peak is noticed towards the LL antigen 
occurring at 5.7months. 
Y111: Patient Y111 in reactivity with total IgG showed an interesting trend also as 
serum antibody levels in response to the LL antigen had greater activity than towards 
HCF antigens (Table5. 3, Figure 5.11A); response from HCF was almost a flat line. 
With subclass IgG1, a contrasting result to that obtained for total IgG was obtained 
for both antigenic samples, they both showed a flat line response (Figure 5.11B). A 
completely different result was obtained for reactivity with subclass IgG4. A flat line 
response was obtained for LL antigen while a rising and falling trend was obtained 
for HCF with significant peaks at 0, 0.78, just before 23.07, and just after 
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23.07months (Figure 5.1C). With this patient, the LL was found to give greater 
response with total IgG, and HCF gave higher response with IgG4. 
Y179: Patient Y179. With this patient, a rising and falling trend was observed for LL 
antigen in response to total IgG, while a flat line trend is exhibited by HCF, only 
showed a raised activity from 12.23momths through to 42.71months. The LL antigen 
showed peaks at 0.33, 14.89 and 42.71months respectively (Figure 5.12A). Figure 
5.12B shows reactivity with IgG subclass 1, and with both antigenic samples, LL and 
HCF, a flat line trend was observed in contrast to response to total IgG (Figure 
5.12A). Results obtained for reactivity with IgG subclass 4 is slightly similar to that 
obtained for IgG subclass 1 in that both antigenic samples responded with a flat line 
before both rising at 14.89months and both peaking at 20.15months and then 
experiencing a sharp fall (Figure 5.12C). 
Y235: Patient Y235. With this patient, reactivity of the two antigenic samples, LL and 
HCF with total IgG and IgG subclasses 1 and 4 have exhibited low responses. HCF 
shows a flat line response with total IgG while LL displayed a rising and falling 
pattern, peaking significantly at 1.02 and 5.19months (Figure 5.13A). In contrast, 
with subclass IgG 1, LL displayed a flat line response while HCF showed a rising and 
falling pattern, peaking significantly at 5.19months (Figure 5.13B). HCF continued 
with its display of rising and falling pattern in response to IgG subclass 4, peaking 
significantly at 0 and 5.29months while a flat line response was maintained by the LL 
(Figure 5.13C). 
156: Patient 156. Here, we see the LL performing and responding better to the total 
IgG antibody, peaking at just after 0 and 1.02months significantly. Both antigenic 
samples almost exhibited the same response and are considered medium 
responders (Figure 5.14A). With IgG subclass 1, again HCF is observed to continue 
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in showing the rising and falling pattern, peaking significantly at just after 1.02 and 
2.3months. The LL shows a flat line response with a not so significant peak  (Figure 
5.14B). Both antigenic samples display the same response to immunoglobulin 
isotype 4 . Both are considered low responders, although HCF has a higher 
response compared to LL, both sample show a peak at just after 0months before 
falling, and then HCF is seen to rise again at 0.56months (Figure 5.14C).  
 
 
 
 
 
 
 
104 
 
 
Figure 5.1: Graphs showing reactivity of HCF and LL with total IgG (A), IgG1 (B) and IgG4 
(C). As evident on graphs, a flat line reaction was displayed by both samples. 
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Figure 5.2: Graphs showing reactivity of HCF and LL with total IgG (A), IgG1 (B) and IgG4 
(C). Trend lines are not the same and the LL appears to be reacting well as HCF or even 
better as depicted in Fig 5.2a. 
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Figure 5.3: Graphs showing reactivity of HCF and LL with total IgG (a), IgG1 (b) and IgG4 
(c). A flat line reaction is recorded for both samples in reactivity with these antibody 
molecules. 
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Figure 5.4: Graph showing reactivity of HCF and LL with IgG (a), IgG1 (b) and IgG4 (c). The 
lines obtained here are varied. The most reaction going on is with HCF and IgG1. 
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Figure 5.5: Graph showing reactivity of HCF and LL with total IgG (a), IgG1 (b) and IgG4 (c). 
Both samples show the same pattern, although LL gives a higher response with all three 
antibody molecules particularly with total IgG (Figure 5.5a). 
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Figure 5.6: Graph showing reactivity of HCF and LL with total IgG (A), IgG1 (B) and IgG4 
(C). The same trends are displayed by IgG (A) and IgG1 (B) and a completely different, 
almost negative flat line observed with IgG4 (C). 
C 
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Figure 5.7: Graphs showing reactivity of HCF and LL with total IgG (A), IgG1 (B) and IgG4 
(C). Very low reaction obtained for both samples with all three antibody molecules. 
A 
C 
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Fig 5.8: Graph showing the reactivity of HCF and LL with total IgG (A), IgG1 (B) and IgG4 
(C). The LL is seen to have the higher response with total IgG (A), IgG1 (C), although both 
samples display same pattern of response. 
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  Fig 5.9: Graphs showing the reactivity of HCF and LL with total IgG (A), IgG1 (B) and IgG4 
(C). Here, HCF is seen to have given the higher response. Reactivity with LL is very low. 
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Figure 5.10: Graphs showing reactivity of HCF and LL with total IgG (a), IgG1 (b) and IgG4 
(c). Here, LL is observed showing a rising and falling pattern of response (Fig 5.10a, b). HCF 
displays a flat line response with all three antibody molecules. 
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Figure 5.11: Graphs showing reactivity of HCF and LL with total IgG (A), IgG1 (B) and IgG4 
(C). LL gave a high response with total IgG (Fig 5.11a), low response for both samples with 
IgG1 and IgG4 (Fig 5.11b and c, respectively). 
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Figure 5.12: Graphs showing reactivity of HCF and LL with total IgG (A), IgG1 (B) and IgG4 
(C). A very low response is observed for both samples here. HCF (Fig 5.12c) is seen 
exhibiting a sharp peak at 20.15months before falling. 
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Figure 5.13: Graphs showing reactivity of HCF and LL with total IgG (A), IgG1 (B) and IgG4 
(C). Line trends are similar for both samples particularly with total IgG and IgG1 (Fig 5.13a 
and b, respectively). HCF is a higher responder with IgG4. 
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Figure 5.14: Graphs showing the reactivity of HCF and LL with total IgG (a), IgG1 (b) and 
IgG4 (c). With total IgG (Fig 5.14a), both samples appear to have responded equally, while 
with IgG1 (Fig 5.14b) and IgG4 (Fig 5.14c) HCF is seen to have slightly higher than the LL. 
A 
B 
C 
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5.3 DISCUSSION  
The usefulness of imaging techniques such as MRI, X-ray or Ultrasonography for 
follow-up of CE patients cannot be over emphasized. However, these techniques 
pose a difficulty in detecting the newly growing small cyst and also to discriminate 
between dead and viable cysts (Wen et al, 1993). Amongst the tests commonly used 
for the follow-up of CE patients are the enzyme-linked immunosorbent assay 
(ELISA) and immunoblotting and are used conventionally with the inclusion of crude 
hydatid cyst fluid, which so far has become the major source of antigen used for this 
purpose (Force et al, 1992; Ravinder et al, 1997; Poretti et al, 1999; Zarzosa et al, 
1999; Gadea et al, 2000; Nouir et al, 2008). Efforts have therefore been directed at 
applying immunological tests of significantly diagnostic and prognostic values. ELISA 
and immunoblotting for serum antibody detection making use of various antigen 
preparations, including crude hydatid cyst fluid, purified fractions of antigen B and/ or 
5, and E. granulosus protoscolex soluble extract have all been applied to follow-up 
CE patients (Sbihi et al, 1996; Gadea et al, 2000; Doiz et al, 2002; Rigano et al, 
2002; Lawn et al, 2004; Ben Nouir et al, 2008). 
    Nevertheless, problems mainly related to temporally delayed reactions to clinical 
changes were displayed by all of these tests (Rigano et al, 2002; Nouir et al, 2008).  
Recombinant antigen B (rAgB) proves to have similar diagnostic value to native 
antigen B in CE patients (McVie et al, 1997; Mamuti et al, 2004). Nevertheless, little 
or no appliaction of rAgB has been used for post-treatment follow-up of CE patients. 
A lot substantiated when Nouir et al, (2008) did their study on the assessment of E. 
granulosus protoscolex soluble somatic antigens (PSSAs).  Their prognostic value in 
the serological follow-up of young patients treated for cystic echinococcosis (CE), 
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compared to conventional hydatid fluid (HF) antigen was assessed. They recorded a 
gradual decrease in antibody levels in CE cases were shown by an Immunoglobulin 
G (IgG)- PSSA enyme-linked immunosorbent assay (ELISA). At least, seronegativity 
was reached in 20% of cases within 5 years post surgery in comparison to the 
standard IgG-HF ELISA which displayed a significantly lower progressive decrease 
in antibody levels, with serology only becoming negative in 15% of CCE patients at 
the endpoint of work has been done in trying to find the antigens other than native 
hydatid cyst fluid suitable for follow-up of CE patients, and this was of the follow-up 
period. They therefore came to a conclusion that PSSA represents a useful 
candidate to carry out a serologic follow-up of CE subsequent to treatment and 
deserves further respective evaluation for other age groups of CE patients. 
 
The purpose of this study is to assess the potential usefulness of E.granulosus LL 
antigen as a marker in post treatment follow-up. In this study, 14 samples i.e only 14 
sera samples from 14 confirmed hydatid disease patients were tested, 4 untreated 
and 10 treated samples. They were tested using the enzyme-linked immunosorbent 
assay for follow-up after treatment. In contrast to E. multilocularis and the Em2 
antigen preparation Gottstein et al, (1992) little work has been carried out using the 
LL of E. granulosus. 
Results in the current study show that the ELISA assay is a sensitive robust 
immunological tool for use in follow-up surveillance of CE patients. As already 
established,  predominance of IgG1 and IgG4 are associated with seropositive 
individuals (Aceti et al, 1993; Wen and Craig, 1994; Ioppolo et al, 1996; Shambesh 
et al, 1997; Sterla et al, 1999; Daeki et al, 2000). In this study, results show that 
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reactivity of serum antibodies show a similar level of response to both the LL and 
HCF antigens, however, in some instances levels appeared higher towards the LL 
antigen. 
A very high reactivity and predominance of IgG1 and IgG4 would have been 
expected from our study, especially for all 4 of our untreated patients since 
predominance of IgG1 and IgG4 is associated with disease progression and 
development (Daeki et al, 2000), however, results show that reactivity was low and 
in some cases a near negative result was recorded. One reason for this may be that 
the cysts of these individuals have deteriorated slowly over time to a state of 
calcification and had died a natural death (Romig et al, 1986; Morris, 1986; 
Pawlowski, 1997; Wang et al, 2003; Wang et al, 2006). According to Levine and 
Grantham (1992), cyst calcification is possible in patients who suffer also from 
autosomal dominant polycystic kidney disease (ADPKD), are older, have larger 
kidneys and worse renal function. 
 Again, there is not much discrepancy with results obtained for our treated patients/ 
samples. Results obtained here are very much in line with desired outcomes. A 
decline in the concentration of IgG1 and IgG4 is expected with cases characterised 
by cyst infiltration and/ or calcification (Daeki et al, 2000), our results agree with this 
as with all our treated patient samples. The reactivity of IgG1 and IgG4 especially 
with the laminated layer of E. granulosus showed very little reactivity. Low response 
was recorded for these IgG subclasses except for when a higher response was also 
recorded for the laminated layer of E. granulosus in reactivity with IgG1 with patient 
Y88 and for HCF with patients Y13 and Y51. A higher response was also recorded 
with patient Y88 with IgG4 and with patient Y235 both HCF and laminated layer of E. 
granulosus gave a higher response with IgG4. Patient Y13 was treated at 2.8months 
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with 3 courses of albendazole (ALB), one course at 22.2months, and another 1 
course at 58.7months and had cystectomy at 62.3months. Even though patient Y13 
was treated, the patient sample still gave a reaction with IgG1 up until 26months 
before exhibiting a flat line, which at this time could be said to have been cured.  
The concentration of IgG1 was high for patient sample Y51 too. Again, this patient 
was treated with one course of albendazole (ALB) at 1.6months and went from a 
CE1 to CE3 and then to CE4. The reaction though, could be false positive. Subclass 
IgG1 and IgG4 responded high to the LL antigen with patient Y88. Patient Y88 was 
treated with 2 courses of ALB at 4.8 months, one course at 7.8 months. According to 
notes that were recorded by the ultrasonographer (AMREF database), the cyst in 
this patient remained as a CE1 type which most likely explains the high response in 
obtained results. Both HCF and laminated layer are high for patient sample Y235. 
The patient was treated with one course of ALB at 2.2months and went from a CE2 
cyst to a CE3. 
The current study, as stated earlier was carried out in order to investigate the 
possibility of the use of the laminated layer of E. granulosus in post-treatment follow-
up of CE patients. Our results show decline in the concentration of IgG1 and IgG4 
especially which correlates to regression of disease. Antibody response, particularly 
IgG4 is associated with cystic development, progression and growth (Daeki et al, 
2000). Results presented here agree with those of Guerri et al, (2000); Rigano et al, 
(1995); and Rigano et al, (1996) that IgG4 subclass is a good marker for follow-up 
surveillance of CE even in this case with the laminated layer of E.granulosus. 
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CHAPTER 6   
GENERAL DISCUSSION 
Very little attention has been given to the immunological analysis of the laminated 
layer of E. granulosus considering the significance of this structure and the 
importance of the diagnostic antigens in the laminated layer of E.multilocularis. 
The current study was carried out to investigate and analyse the laminated layer of 
E. granulosus with a view to the potential for its use in the post-treatment follow-up of 
CE. 
Immunodiagnosis of hydatid disease in the past has always adopted the use of 
native hydatid cyst fluid as the antigenic material. Little attention has been given to 
the immunoreactivity of human cystic hydatid sera against the laminated layer of E. 
granulosus. The presence of large carbohydrates on the surface of the laminated 
layer perhaps make it less suitable for solid phase immunoassays such as the 
ELISA. However, the present study indicates that, with the use of crude sonicate, the 
laminated layer would as well as or even yield a higher response as the case may 
be. 
Lectins have been used in the past and have been involved in the general molecular 
characterization of the laminated layer of the Echinococcus species. Kouguchi et al, 
(2011) Showed how a conventionally purified glycoprotein component of 
Echinococcus multiloularis protoscolex , designated as Emgp-89, may be useful as a 
serodiagnostic antigen for detecting E. multilocularis infection in dogs domesticated 
in endemic areas. They obtained Emgp-89 from the parasite material by a simple 
procedure using ConA-agarose and subsequent gel filtration chromatography. A 
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molecular weight of >4000KDa was showed by the purified fraction upon gel filtration 
and reacted with a series of lectins that specifically bind to mannose, galactose, N-
acetylglucosamine, and N-acetylgalactosamine. Evaluation of the serodiagnostic 
performance of Emgp-89 was through enzyme-linked immunosorbent asssays 
(ELISAs) by using sera from normal, domestic dogs and dogs infected with other 
helminths. Emgp-89 positively reacted with all 16 serum samples from 
E.multilocularis- infected dogs, thus showing that this antigen is highly sensitive. 
Although, they didn‘t break down their obtained molecular weight, but the result of 
this present agrees with results obtained by Kouguchi et al, (2011) in that mannose, 
N-acetylglucosamine and N-acetylgalactosamine were recognised by our lectin 
samples too. 
Arana et al, (2013) also carried out a study on the carbohydrate composition of  
Taenia solium whole oncosphere antigens (WOAs), in order to improve the  
understanding of the antigenicity of the T. solium. For accurate diagnosis of previous  
exposure to T. solium eggs and thus predict the development of cysticercosis, better  
knowledge of oncosphere is absolutely important. In their study, a set of 7 lectins  
conjugates with wide carbohydrate specificity were used on parasite fixations and  
some somatic extracts. According to them, lectin fluorescence revealed that D- 
mannose, D-glucose, D-galactose and N-acetyl-D-galactosamine residues were the  
most abundant constituents of carbohydrate chains on the surface of T. solium  
oncosphere. Their lectin blotting also showed that posttranslational modification with  
N-glycosylation was abundant while little evidence of O-linked carbohydrates was  
observed. They demonstrated, for the first time, that the presence of several lectins  
on the surface of the oncosphere was specific to carbohydrates found in intestinal  
mucus, suggesting a possible role in initial attachment of the parasite to host cells.  
Again, the result of the current study agrees with that of Arana et al, (2013) obtained  
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result. Carbohydrates such as mannose, N-acetylgalactosamine and galactose were  
recognised. 
Results of SDS carried out show the fractions of LL recognising bands at the same 
regions as the HCF thereby suggesting the presence of AgB. Extracts of crude 
laminated layer were purified using the Affinity chromatography technique. The 
collected eluates were used in ELISA even though the assay worked, results show 
that higher response was derived when tested with total IgG while with the other two 
subclass immunoglobulins 1 and 4., the results show correlation with results 
obtained from the current study where with virtually all assays done, IgG1 and IgG4 
is on the decline especially samples from treated patients.   
For this part of the current study, the aim and ultimate plan was to purify the  
laminated layer of E. granulosus and then use the obtained purified extract in further  
serological investigations to be able to ascertain the serodiagnosis and general  
molecular capacities. As stated earlier, encouraging results were not obtained for the  
ELISA assay and therefore, it was decided not to go ahead with the other assays,  
but this does not negate the fact that the affinity chromatography is an established  
molecular tool that has proved very useful in molecular diagnosis and has been  
employed by various researchers in different laboratories around the globe.Isolation  
and characterization of cestode-derived antigens of infected hosts have been  
advocated with regard to elimination of cross-reactivity to improve immunodiagnostic  
tests (Ito and Smyth, 1987). In their study, Elayoubi and craig (2004) aimed at the  
prospect of the fractionation of immunodiagnostic-relevant E. granulosus antigens  
directly from faecal samples of infected dogs or from adult worm extracts using size-  
exclusion fast protein liquid chromatography (FPLC), and the subsequent  
biochemical characterization of the partially purified antigens. 
The FPLC results indicated that at least 2 major antigenic components or fractions  
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(F1 and F2) with different large molecular weights (>670KDa and 146-440KDa  
respectively) were specifically present in faecal supernatants from E. granulosus-  
infected dogs as demonstrated by coproantigen capture ELISA. These 2 high  
molecular weight fractions probably represent the effective coproantigen activity that  
is detectable by the Echinococcus coproantigen ELISA (Elayoubi and Craig, 2004). 
The assy again has also been used by Gottstein et al, (1983) when they isolated a  
specific fraction (Em2) from crude metacestode of the E.multilocularis by  
immunoaffinity chromatography against anti-E.granulosus hydatid fluid IgG coupled  
to CNBr-Sepharose 4B. This antigen has a molecular mass of 54KDa and is located  
within the LL (Gottstein, 1985; Furuya et al, 1989; Gottstein, 1992). Em2 is now  
confirmed as species-specific antigen and WHO recommends the Em2-ELISA as a  
reference immunodiagnostic test for alveolar echinococcosis. 
A partially purified Em 18/16 enriched fraction from E. multilocularis LL prepared by  
isoelectric focusing (Ito et al, 1997), may have a greater specificity than the Em2  
(plus)-ELISA. Since cyst fluid contained two antigens (are 5 and antigen B), both  
antigens have shown to have cross reactions with other helminths in particular E.  
multilocularis and Taenia solium (Craig et al, 1995). 
 
Taherkhani and Rogan, (2001) also decided to investigate the immunogenicity of the  
laminated layer of E. granulosus with respect to its role in immunodiagnosis. They  
attempted to remove host components such as sheep serum and / or sheep IgG, by  
preparation of a semi-purified LL fraction using an affinity chromatography column  
and to evaluate its antigenic reactivity by SDS-PAGE and immunoblotting. They  
found the normal LL showed bands in the 50-55KDa region and the 27-31KDa   
which presumably reflected the removal of heavy and light immunoglobulin chains. 
 
However, the most useful aspect of the laminated layer in terms of serodiagnosis  
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was evident in immunoblotting. This indicated that the bands at 66, 55, 29 and  
27KDa were significant molecules for diagnosis of human cystic hydatidosis patients.  
Since total IgG and IgG4 subclass antibody responses in positive sera recognised  
major bands in the 25 up to 29KDa region (much stronger at 29KDa) in unpurified  
LL, in the 25-31KDa (much stronger at 27KDa) in Px and one obvious band at  
27KDa in semi-purified LL. 
 
Extracts of laminated layer was immunoblotted against total IgG, IgG1 and I gG4, as 
evident on graphs (figure 3.5 and 3.6), where the LL especially detects no band 
against these two subclasses of IgG..  
Again, the immunodiagnostic strength and capacity of the laminated layer of E 
granulosus was put to test when the LL was reacted with total IgG, IgG1 and IgG4 
with sera from confirmed CE patients from Turkana , Kenya. Fourteen samples were 
tested in all, four untreated and 10 treated. Again, a decline in the response towards 
IgG1 and especially IgG was recorded. This could be due to the fact the cyst 
presented by these patients have undergone calcification over time and may have 
died a natural death. Follow-up after treatment of CE and AE is highly important and 
necessary to be able to monitor relapse, recurrence and/ or cure. This was shown in 
the work of Dreweck et al, (1997) when they evaluated Immunoglobulin subclass-
specific antibody responses and isotype-specific recognition of E. multilocularis  and 
E. granulosus  antigens  in both alveolar echinococcosis and cystic echinococcosis. 
AE patients were divided into 3 groups by clinical and therapeutic criteria according 
to their actual state of infection, i.e, elimination of parasite, and regression or 
progression of disease. CE patients were either before or after surgery, or in 
continuous chemotherapy due to parasite persistence. Total IgE was highly elevated 
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in progressive AE cases (7/11), but not in the cases with eliminated infection or 
regression. In patients with active AE disease, EmAg-specific IgE, total IgG, IgG1, 
IgG2 and IgG4 were particularly high. Similarly, total IgE was raised beyond 
reference values in 9 of 30 CE patients indicating progressive disease. CE patients 
sera antibody cross-reacted with crude EmAg, and detectable Ig levels of the same 
isotype were also measured by ELISA. In both AE and CE, parasite-specific antigen 
recognition was dominated by IgG1 and IgG4. In AE patients with progressive 
disease, IgG4 distinctively recognised low molecular weight EmAg of 26KDa, 
18KDa, 16KDa and 12KDa. As prominent IgG4 and IgE responses develop with 
chronic helminth infections only, these serological parameters may indicate 
successful parasite infestation and severe outcome of disease. They submitted that 
analyses of immuogloblin isotype responses in AE patients by ELISA in combination 
with immunoblotting are a useful approach for post-treatment follow-up of patients at 
risk of developing recrudescent disease. 
 From the current study, results have shown that and agreed with the work carried 
out by Dreweck et al, (1997) by showing bands at and with low molecular weights in 
the region of 18KDa especially and also followed by the antibody specific response. 
IgG4 , especially with all our treated patients samples was on the decline, which 
could be pointing at the fact that treatment obtained and given to these patients have 
been successful as prominent IgG4 is only associated with chronic disease. Also, it 
shows that IgG4 is a reliable serological parameter in the diagnosis and follow-up of 
cysytic echinococcosis. 
Overall, all of the assays employed in the current study have worked successfully to 
their optimum. Results obtained have not only shown the laminated layer of E. 
granulosus to be composed of antigenic materials but also it has indicated that the 
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laminated layer of E. granulosus can be employed as an antigenic material in the 
immunodiagnosis and post- treatment follow-up of CE. We would like to suggest that 
further work be carried out to substantiate this. 
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APPENDIX 
 
For SDS-PAGE: 
Acrylamide                                              
29.2g Acrylamide                                     
0.8g N'N'-Bis methylene acrylamide 
Make up 100ml ddH₂O 
Filter and store at 4℃ in dark.  
 
10% SDS 
1g SDS in 10ml ddH₂O 
 
TRIS BUFFERS: 
 
1.5M Tris pH 8.8                                    
Add 18.15g Tris base to 50ml ddw           
   
To pH 8.8 with 1M HCl                            
100ml with ddH₂O 
 
0.5M Tris pH 6.8 
Add 6.0g Tris base to 50ml ddH₂O 
Adjust to pH 6.8 with 1M HCl 
Make up to100ml with ddH₂O 
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Running buffer: pH 8.3 for 1L 
3.03g Tris base 
14.42g glycine 
Make up to 1L with ddH₂O 
 
Dithiothreitol (DTT) 0.1% 
Bpb stock 
1.39g DTT in 6ml of 0.1% Bpb 
10ml 0f 10% SDS stock 
 
0.1% Bromophenyl blue (Bpb) 
0.01g Bpb in 10ml ddH₂O 
 
Coomassie Blue stain 
1g Coomassie brilliant blue 
450ml methanol 
100ml acetic acid  
Make up to 1L with ddH₂O 
 
Ammonium peroxidise (APS) 
0.1g APS in 1ml ddH₂O 
 
Drying reagent 
100ml acetic acid 
10ml glycerol 
Make up to 1L with ddH₂O 
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De-stain solution 
35ml acetic acid 
100ml methanol 
365ml ddH₂O 
Make up to 500ml with ddH₂O 
 
12.5% 1mM Tris-glycine separating buffer 
12.5ml acrylamide stock 
11.2ml Tris HCl pH 8.8 
6.2ml ddH₂O 
Total volume 29.9ml 
 
 
5% seperating gel 
1.25ml Tris ph 6.8 
1.67ml acrylamide stock 
7.o3ml ddH₂O 
Total volume 9.95ml 
 
 
Sample cocktail 
1.88ml Tris ph 6.8 
6.0ml 10%SDS 
3.0ml Glycerol 
2.12ml ddH₂O 
Total volume 13ml 
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FOR ELISA : 
 
Diethanolamine buffer pH 9.8 
10mg MgCl₂ 6H₂O 
9.7ml diethanolamine 
Make up to 100ml with ddH₂O 
Adjust pH using drops of 1M HCl to lower pH or 2M NaoH to raise pH.  
 
Bicarbonate carbonate buffer 
4 BCB capsules 
400ml ddH₂O 
 
Phosphate buffer saline (0.1% PBS T20 wash buffer) 
4 PBS tablets  
 
0.8ml Tween 20 
800ml ddH₂O 
 
Blocking buffer (0.3% PBS T20, 5% milk solution) 
1 PBS tablet 
0.6ml Tween 20 
200ml ddH₂O 
And from stock 
100ml o.3% PBS T20 
5g skimmed milk 
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For Western blot: 
 
Bromochloroindolyl phosphate (BCIP) 
1 BCIP tablet in 10ml ddH₂O 
 
0.15M NaCl2, 0.01M Tris-HCl containing 0.5mM CaCl2 (pH 7.4) 
C4H11O2 (Tris)                                                    2.422g 
NaCl2                                                                    17.53g                                                              
CaCl2                                                                     0.111g 
DDW                                                                       1600ml 
Adjust pH to 7.4 with 0.1M HCl2 and make up to 2litre with DDW. 
 
Eluting Buffer (0.2M Glycine HCl, pH 3.0) 
Glycine                                                                     1.5g 
NaCl                                                                          2.94g 
DDW                                                                          80ml 
Adjust to pH 3.0 with 1M HCl, and make up to 100ml with DDW. 
 
 
 
 
 
 
 
